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REGULATION OF THE ESCRT FUNCTION OF ALIX

Sheng Sun, M.S.

Advisory Professor: Jian Kuang, Ph.D.

The ESCRT (endosomal sorting complex required for transport) is an
evolutionary conserved membrane remodeling machinery that performs membrane
invagination and abscission. ALIX is a widely expressed adaptor protein that is critically
involved in three classical ESCRT-mediated processes, including MVB (multivesicular
body) sorting, cytokinetic abscission and retroviral budding. Previous studies have
demonstrated that ALIX involvement in these ESCRT-mediated processes requires
ALIX interaction with the ESCRT-III component CHMP4 as well as a cargo protein.
However, the native form of ALIX contains a default intramolecular interaction between
N-terminal Bro1 domain and C-terminal PRD (proline-rich domain), leading to a closed
conformation of ALIX that cannot interact with CHMP4. This predicts that ALIX
involvement in ESCRT-mediated processes requires an activation step that relieves the
intramolecular interaction of ALIX.
The objective of my dissertation research is to identify the regulatory
mechanisms that activate the ESCRT function of ALIX in the three classical ESCRTmediated processes. Whether ALIX is critically involved in MVB sorting of ubiquitinated
receptors has been controversial. By examining the effects of ALIX on the level of
activated EGFR in the lumen of MVB and the level of EGF-induced phosphorylated
ERK1/2, which is the downstream signaling of activated EGFR, I showed that CHMP4vi

bound ALIX dimer plays an essential role in MVB sorting and silencing of activated
EGFR. However, MVB sorting of activated EGFR is not required for its degradation. My
studies thus identify ALIX as an important regulator for signaling output of the activated
EGFR. I further demonstrated that ALG-2 (apoptosis-linked gene 2 product) is
responsible for generating ALIX in open conformation that supports MVB sorting and
timely silencing of activated EGFR. My studies thus identify ALG-2 as a potential
negative regulator for the signaling transduction of activated EGFR and provide a new
understanding for the role of ALG-2 in apoptotic induction.
While ALG-2 is important for ALIX-mediated MVB sorting, I found that ALG-2 is
not important for ALIX-mediated cytokinetic abscission or retroviral budding. Thus, I
further identified mechanism that activates ALIX in these two ESCRT-mediated
processes. By studying mitotic phosphorylation of ALIX, I found that phosphorylation at
S718 and S721 residues in the PRD domain of ALIX relieves the intramolecular
interaction of ALIX. This mechanism is required for generating ALIX in open
conformation that supports cytokinetic abscission and retroviral budding. These
findings provide a new understanding for the regulation of cytokinesis and retroviral
budding and may provide new strategies for inhibiting cell division and retroviral
budding.
In summary, my dissertation studies have identified two regulatory mechanisms
that relieve the intramolecular interaction of ALIX in the three classical ESCRTmediated membrane remodeling processes. These studies provide insights into the
regulation of ESCRT-mediated membrane remodeling processes and suggest that
ALIX may be a potential target for anti-cancer and anti-viral therapy.
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Chapter 1: Introduction

1.1.

Endolysosomal trafficking of cell surface receptors
Ligand binding to cell surface receptors induces the activation of receptors,

which then induces the internalization of these activated receptors in membranebounded vesicles through a plasma membrane invagination process, called
endocytosis (Marsh and McMahon, 1999). These receptor-containing vesicles are then
fused with early endosome.
From early endosome, there are three fates for these receptors. First, receptors
can recycle back to cell surface. During the recycling process, these receptors still have
signaling function, activating the downstream signaling pathways. Second, receptors
can stay on the membrane of early endosome. This portion of receptors also keeps
their signaling function. The third fate is to be sorted into the lumen of early endosome
through an endosome membrane invagination and abscission process, called MVB
(multivesicular body) sorting.
MVB sorting terminates the signaling function of the activated receptors and it is
a very quick process, happening in ~30 min after ligand binding. Although the receptors
both on the membrane and in the lumen of early endosome will be trafficked to late
endosome and then lysosome for degradation, receptors staying on the endosome
membrane will keep on sending signals to the downstream pathways during the
trafficking process, which takes several hours. Thus, if activated receptors are not
properly sorted into endosome through MVB sorting, the duration of the downstream
signaling will be prolonged and it may lead to uncontrolled cell proliferation. Thus, MVB
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sorting is an important process that functions as a negative regulator of activated
receptors.
The whole process initiating from endocytosis of the activated receptors until to
lysosome-dependent degradation of these receptors is called endolysosomal trafficking
(Feyder et al., 2015; Goh and Sorkin, 2013; Mellman, 1996; Scott et al., 2014; Sorkin
and Goh, 2009; Wegner et al., 2011) (Fig. 1).

2

Figure 1. Endolysosomal trafficking of cell surface receptors. Endolysosomal
trafficking initiates from the receptor activation-induced endocytosis. The endocytosed
receptors either recycle back to cell surface (1), stay on the membrane of early
endosome (2) or are sorted into the lumen of early endosome (MVB sorting) (3). Then,
MVB will be fused with lysosome to deliver receptors for lysosome-dependent
degradation.
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1.2.

Discovery of ESCRT and its MVB sorting function
MVB sorting is in the opposite topology of endocytosis. While endocytosis

involves budding of vesicles into cytoplasm, MVB sorting involves budding of vesicles
away from cytoplasm (Fig. 1). Thus, the mechanism underlining endocytosis does not
apply to MVB sorting. Therefore, it is important to have a powerful model system to
study the mechanism underlining MVB sorting. The researchers found that yeast
Saccharomyces cerevisiae is the most powerful model system for studying MVB sorting
for several reasons. First, MVB sorting pathway is conserved from yeast to human. In
yeast cells, membrane proteins also go through MVB sorting to vacuole, the
intracellular organelle sharing functional characteristics with mammalian lysosome
(Banta et al., 1988; Henne et al., 2013). Second, it is convenient to perform genetic
screen in yeast to search for the genes, whose products are involved in MVB sorting.
Plasmids with no gene-specific sequences can be delivered into yeast cells and these
sequences can integrate randomly throughout the genome and randomly disrupt the
genes to generate various mutant yeast strains. Through observing the expected
phenotypes, which are the abnormal morphology of endosome and the defective
sorting of GFP-labelled vacuole enzyme, carboxypeptidase S (CPS), the researchers
could identify the genes that are required for normal MVB sorting pathway (Banta et al.,
1988; Forsburg, 2001). Third, the phenotypes induced by defective MVB sorting can be
easily observed under microscope (Banta et al., 1988; Raymond et al., 1992; Robinson
et al., 1988).
By using yeast as the model system, Emr and Stevens groups found that loss of
several genes in yeast led to exaggerated endosome-like compartment (the class E
compartment) and defective sorting of vacuole enzyme. They named this type of genes,
4

which is required for MVB sorting, as Class E Vps (vacuolar protein sorting) (Banta et
al., 1988; Raymond et al., 1992; Robinson et al., 1988).
Further biochemical and cellular studies from Emr group found that products of
Class E genes Vps23, Vps28, and Vps37 form a protein complex, which binds the
ubiquitinated sorting receptors in yeast. They named this protein complex as ESCRT-I
(endosomal sorting complex required for transport-I) (Katzmann et al., 2001). Then,
they found that products of Class E genes Vps2, Vps20, Vps24, and Snf7 form a
protein complex, which have direct effects on MVB sorting activity in yeast. They
named this protein complex as ESCRT-III (Babst et al., 2002a). They also found that
products of Class E genes Vps22, Vps25, and Vps36 form a protein complex, which
also binds ubiquitinated sorting proteins, associates with endosome membrane and
interacts with ESCRT-III and promotes its assembly. They named this protein complex
as ESCRT-II (Babst et al., 2002b).
Further studies in mammalian cells revealed that these Class E gene products
are conserved from yeast to human. Mammalian cells contain the orthologs of all these
yeast Class E gene products, which also constitute ESCRT-I, II, and III (Henne et al.,
2013; Hurley, 2010) (Table 1 and Fig. 2). The studies in mammalian cells also identified
a protein complex consisting of STAM (signal-transducing adaptor molecule) and Hrs
(hepatocyte growth factor-regulated tyrosine kinase substrate). This protein complex,
which was shown to bind ubiquitinated sorting receptors, associate with endosome
membrane and is involved in MVB sorting, was named as ESCRT-0 (Table 1 and Fig.
2). Then, the genetic screen in yeast also identified two Class E Vps genes (Hes1 and
Vps27), whose products are orthlogs of mammalian Hrs and STAM, respectively
(Bilodeau et al., 2002; Katzmann et al., 2003) (Table 1).
5

The essence of MVB sorting is linking receptor recognition and endosome
membrane abscission. ESCRT machinery is anchored on the endosome membrane
through direct interaction between ESCRTs-0/-II components and endosome
membrane-associated PtdIns(3)P lipid. ESCRT-0, -I, and -II function as a stable heterooligomers to recognize and concentrate ubiquitinated receptors through the ubiquitinbinding motifs in the components of these three ESCRTs (Fig. 2). ESCRT-II initiates
the sequential activation and assembly of ESCRT-III, which, in default condition, exists
as autoinhibited monomers in the cytoplasm. The formed oligomerized ESCRT-III
filaments localize around the neck of the budding vesicle and perform the membrane
abscission. AAA ATPase Vps4 interacts with ESCRT-III and provides energy to
dissemble the ESCRT-III after MVB sorting (Babst et al., 1998; Boura et al., 2012;
Caillat et al., 2015; Henne et al., 2012; McCullough et al., 2015; Teis et al., 2008; Yang
et al., 2015) (Fig. 2). Thus, ESCRT is evolutionary conserved membrane remolding
machinery that execute MVB sorting pathway.
1.3.

MVB sorting-related functions of ESCRT
Besides MVB sorting, the second identified function of ESCRT is retroviral

budding. ESCRTs were found to be hijacked by retroviruses for their budding away
from the host cells. Retrovirus, such as HIV-1 and EIAV (equine infectious anemia
virus), recruits ESCRT-III to the budding site through direct interaction between
retroviral Gag protein and ESCRT-associated protein (Beata MierzwaVotteler and
Sundquist, 2013; Martin-Serrano and Neil, 2011; Strack et al., 2003; von Schwedler et
al., 2003). The studies by using siRNA knockdown and rescuing experiments indicated
that among the ESCRT-III components, only CHMP4 (charged multivesicular body
protein 4) and CHMP2 are critically involved in HIV-1 and EIAV budding. CHMP4
6

filaments are assembled in circular arrays that bend the plasma membrane away from
the cytoplasm. Then, CHMP4 filaments are “capped” by recruiting CHMP2 subcomplex,
which subsequently binds and recruits Vps4 (Sandrin and Sundquist, 2013).
The third identified function of ESCRT is cytokinetic abscission, the final step of
cell division where daughter cells are physically separated (Carlton et al., 2008; Carlton
and Martin-Serrano, 2007; Morita et al., 2007). The essential event in cytokinetic
abscission is the recruitment of ESCRT-III to the midbody area and its assembly to
oligomerized filaments, which perform the membrane abscission (Carlton et al., 2008;
Carlton and Martin-Serrano, 2007; Morita et al., 2007). Three models have been
proposed for how ESCRT-III filaments promote membrane abscission. One is “spiralingression” model, in which ESCRT-III forms filaments at the midbody and the spiral
filaments wind from the midbody and the end of the narrowing spirals is the abscission
zone. Another one is “sliding spiral” model, in which ESCRT-III forms filaments at the
midbody and the spiral filaments slide along the intracellular bridge to form an
abscission site ∼1 μm from the midbody. The third one is “vesicle-mediated ingression”
model, in which intracellular vesicles derived from recycling endosomes form the
abscission zone by narrowing the intercellular bridge through fusion with the plasma
membrane (Henne et al., 2013).
MVB sorting, cytokinetic abscission and retroviral budding are three bestcharacterized ESCRT-mediated processes with the same topology. Therefore, these
three processes are called classical ESCRT-mediated processes (Fig. 3). Besides
these three classical ESCRT-mediated processes, multiple novel functions of ESCRT
have been reported recently, including exosome biogenesis (Baietti et al., 2012),
plasma membrane wound repair (Jimenez et al., 2014; Scheffer et al., 2014),
7

autophagy (Murrow et al., 2015) and nuclear envelope reformation (Olmos et al., 2015;
Vietri et al., 2015). These novel functions reveal remarkably widespread roles of
ESCRTs in cellular processes.
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Table 1. ESCRT proteins in yeast and mammalian cells

ESCRT-0

ESCRT-I

ESCRT-II

ESCRT-III

Yeast

Human

Vps27

Hrs

Hes1

STAM1/2

Vps23

TSG101

Vps28

Vps28

Vps37

Vps37

Mvb12

hMvb12

Vps36

EAP45

Vps22

EAP30

Vps25

EAP20

Vps20

CHMP6

Snf7

CHMP4

Vps24

CHMP3

Vps2

CHMP2
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Figure 2. Illustration of ESCRT machinery in mammalian cells. The subunits of
each ESCRT complex and Vps4 are shown. ESCRT-0 component STAM (signaltransducing adaptor molecule), ESCRT-I component TSG101 (tumor susceptibility
gene 101) and ESCRT-II component EAP45 contain ubiquitin binding motifs that
recognize ubiquitinated cargo proteins.
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Figure 3. Three classical ESCRT-mediated processes. MVB sorting of internalized
receptors, cytokinetic abscission and retroviral budding are three classical ESCRTmediated processes, having the same topology (budding away from cytoplasm) and
sharing the mechanism for membrane invagination and abscission (requiring ESCRTs).

11

1.4.

ESCRT-associated protein: ALIX
Through the genetic screen of the mutant class E Vps genes leading to defective

MVB sorting of GFP-Labelled CPS in yeast, Emr and his colleagues identified that
product of BRO1 (BCK1-like Resistance to Osmotic shock) gene is required for normal
MVB sorting pathway (Odorizzi et al., 2003). BRO1 protein consists of three domains:
an N-terminal Bro1 domain, a middle V letter-shape domain and a C-terminal prolinerich domain (PRD) (Odorizzi, 2006; Odorizzi et al., 2003). BRO1 binds ubiquitinated
receptors through its ubiquitin-binding motif in the V domain and this ubiquitin-binding
activity is required for BRO1 to support MVB sorting pathway (Pashkova et al., 2013).
BRO1 also interacts with ESCRT-III component Snf7 through its Bro1 domain and
regulates the assembly and the membrane abscission capability of ESCRT-III filament
(Odorizzi et al., 2003; Wemmer et al., 2011). Thus, BRO1 functions to link the receptor
recognition and ESCRT-III mediated membrane abscission.
ALIX (ALG-2 interacting protein X) (Missotten et al., 1999), also termed AIP1
(Vito et al., 1999) was initially identified and cloned by two independent studies
searching for partner proteins of ALG-2 (apoptosis-linked gene 2 product) in mouse.
Structural studies of ALIX revealed that ALIX and BRO1 share structural organization.
ALIX also consists of three domains: an N-terminal Bro1 domain, a middle V lettershaped domain and a C-terminal PRD (Fisher et al., 2007). The Bro1 domain of ALIX
contains a binding site (hydrophobic Patch 1) for ESCRT-III component CHMP4 and a
docking site (hydrophobic Patch 2) for Src (Kim et al., 2005; McCullough et al., 2008).
The V domain of ALIX contains the ubiquitin-binding motifs for preferably interacting
with Lys-63 polyubiquitin chain (Dowlatshahi et al., 2012; Keren-Kaplan et al., 2013)
and a hydrophobic three dimensional interaction site (F676 pocket) for proteins
12

containing YPX(n)L motif, such as retroviral Gag proteins (Lee et al., 2007; Zhai et al.,
2008), syntenin (Baietti et al., 2012) and PAR1 (protease activated receptor 1) (Dores
et al., 2012a; Dores et al., 2012b). The PRD of ALIX contains two linear docking sites
(residues 717-720 and 852-855) for ESCRT-I component TSG101, an ALIX
multimerization sequence and an ALG-2 binding site (residues 801-812) (Carlton et al.,
2008) (Fig. 4).
As the ESCRT-associated protein, ALIX was first found to be involved in
ESCRT-mediated retroviral budding, during which retroviral Gag proteins directly
interact with the F676 pocket in the V domain of ALIX and through this interaction,
retrovirus hijacks ESCRT-III of host cells to plasma membrane for membrane
abscission (Strack et al., 2003; von Schwedler et al., 2003). Then, ALIX was
demonstrated to be essential for ESCRT-mediated cytokinetic abscission, during which
ALIX is recruited to the midbody through direct interaction with CEP55 (entrosomal
protein of 55 kDa), which is recruited to midbody during cytokinesis. The midbodylocalized ALIX recruits CHMP4 to the midbody area and promotes the assembly of
ESCRT-III filaments, which perform the membrane abscission at the midbody area
(Carlton et al., 2008; Carlton and Martin-Serrano, 2007; Morita et al., 2007).
As the mammalian ortholog of yeast BRO1, ALIX was predicted to be involved in
MVB sorting of ubiquitinated receptors in mammalian cells, just as BRO1 does in yeast
(Pashkova et al., 2013). However, by using EGFR as the model molecule, multiple
previous studies generated negative results by showing that knockdown of ALIX
produced no or only a minor inhibitory effect on degradation of activated EGFR in HeLa
cells (Bowers et al., 2006; Cabezas et al., 2005; Doyotte et al., 2008; Schmidt et al.,
2004). Since MVB sorting is generally thought to be required for lysosome-dependent
13

degradation of activated EGFR, these results led to a widely held notion that ALIX does
not play a critical role in ESCRT-mediated MVB sorting of ubiquitinated membrane
receptor in mammalian cells. However, two independent studies reported that inhibition
of MVB sorting of activated EGFR by treating cells with PI3-kinase inhibitor wortmannin
or by knocking down annexin 1 only generated a minor inhibitory effect on degradation
of activated EGFR (Futter et al., 2001; White et al., 2006), indicating that MVB sorting
may not be necessary for lysosome-dependent degradation of ubiquitinated receptors
in mammalian cells. Thus, the lysosome-dependent degradation of activated EGFR
may not be the reliable indication for MVB sorting of activated EGFR in mammalian
cells. Moreover, both mammalian ALIX and yeast BRO1 contain ubiquitin binding
motifs that interact with Lys63 poly-ubiquitin chain (Dowlatshahi et al., 2012; Pashkova
et al., 2013), indicating that ALIX is probably able to recognize and interact with
ubiquitinated

receptors,

such

as

activated

EGFR,

which

requires

Lys63

polyubiquitination for its lysosome-dependent degradation (Huang et al., 2013).
Therefore, whether ALIX is critically involved in MVB sorting of activated EGFR has
been controversial.
Since MVB sorting of activated receptor tyrosine kinases, such as EGFR, is
involved in timely terminating the signaling function of these receptors (~30 min) before
these receptors are delivered to lysosome for degradation (several hours), thus MVB
sorting is an important regulatory mechanism that prevents uncontrolled cell
proliferation induced by over-activation of receptor tyrosine kinases. Investigating the
role of ALIX in MVB sorting of ubiquitinated receptors will provide great insights into the
regulation of such an important process.
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Figure 4. Schematic diagram depicting the domain organization of ALIX and
BRO1. Mammalian ALIX contains 868 amino acids and yeast BRO1 contains 844
amino acids. In ALIX, Bro1 domain binds ESCRT-III component CHMP4, V domain
binds Lys63 poly-ubiquitinated proteins and PRD binds ESCRT-I component TSG101
and ALG-2. In BRO1, Bro1 domain binds ESCRT-III component Snf7, which is yeast
homolog of CHMP4 and V domain also binds Lys63 poly-ubiquitinated proteins.
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1.5.

Diverse cellular functions of ALIX
Besides ESCRT-mediated processes, ALIX has also been reported to be

involved in diverse cellular processes that do not need involvement of ESCRT. Studies
from Bögler group found that ALIX interacts with focal adhesion kinase (FAK) and
proline rich tyrosine kinase 2 (PYK-2) and through these interactions, ALIX regulates
cell adhesion (Schmidt et al., 2003). Then, studies from our group found that ALIX
directly interacts with F-actin and promotes actin cytoskeleton assembly. We also found
that sub-population of ALIX can be secreted outside of the cells and the extracellular
ALIX is involved in regulating integrin-mediated cell adhesion and extracellular matrix
assembly (Pan et al., 2008; Pan et al., 2006). An important question is what decides
ALIX to function in ESCRT-mediated cellular processes or in ESCRT-independent
cellular processes.
1.6.

The default intramolecular interaction of ALIX
Native form of ALIX contains a default intramolecular interaction between Patch

2 in Bro 1 domain and one of the TSG101 docking site (TSD: residues 717-720) in
PRD (Fig. 5). This intramolecular interaction renders ALIX a closed conformation,
which prohibits ALIX interaction with ESCRT-III component CHMP4 (Zhou et al., 2009;
Zhou et al., 2008; Zhou et al., 2010). Thus, native form of ALIX cannot perform its
ESCRT function. Also, ALIX in the closed conformation exists as the monomer in the
cytosol. ALIX in the open conformation can dimerize through its V domain in an antiparallel manner and this dimerization was proposed to promote the assembly of
CHMP4 filament and required for retroviral budding (Pires et al., 2009; Zhai et al.,
2008). Since ALIX is an essential mediator for linking the upstream initiator and the
downstream executor of ESCRT-mediated processes, investigating the regulatory
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mechanisms that relieve the intramolecular interaction of ALIX will lead to a better
understanding for ESCRT-mediated processes.
Based on the studies from previous graduate student in our group, three
potential regulatory mechanisms that relieve the intramolecular interaction of ALIX were
proposed. One is the partner protein interaction-induced conformational change.
Another one is the competitive binding-induced disruption of intramolecular interaction.
The third one is posttranslational modification-induced disruption of intramolecular
interaction (Zhou et al., 2010).

17

Figure 5. Model depicting ALIX transforming from closed conformation to open
conformation. Native form of ALIX contains a default intramolecular interaction
between Patch 2 in Bro1 domain and TDS in N-terminal portion of PRD, rendering a
closed conformation of ALIX and blocking its ESCRT-functions. The activation of ALIX
initiates from the dissociation of Bro1 domain and PRD. Then, the V domain of ALIX is
open followed by V-domain-mediated anti-parallel dimerization.
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1.7.

The objective of the dissertation
The default intramolecular interaction of ALIX has to be relieved to activate

ESCRT functions of ALIX. Thus, the objective of my dissertation research is to identify
the regulatory mechanisms that activate the ESCRT functions of ALIX in the three
classical ESCRT-mediated processes. To accomplish this objective, I performed three
parts of studies.
First, I comprehensively investigated the role of ALIX in binding, MVB sorting,
silencing and degradation of activated EGFR in HEK293 and HeLa cells. My studies
demonstrate that ALIX binds activated and ubiquitinated EGFR and plays an essential
role in MVB sorting and timely silencing of activated EGFR. However, ALIX does not
play an important role in trafficking of activated EGFR to lysosome for degradation. My
studies thus identify ALIX as an important regulator for the signaling output of activated
EGFR and possibly other receptor tyrosine kinases.
Then, I explored the mechanism that relieves the default intramolecular
interaction of ALIX in MVB sorting process. My studies demonstrate that calciumdependent ALG-2 interaction with ALIX induces a conformational change of ALIX that
relieves its intramolecular interaction. ALG-2-supported activation of ALIX is required
for ALIX to associate with membrane-bound CHMP4 and function in MVB sorting of
activated EGFR. In contrast, ALG-2-supported activation of ALIX is not required for
cytokinetic abscission or retroviral budding. My studies thus identify ALG-2 as a
potential negative regulator of signaling transduction of activated EGFR and provide a
new understanding for apoptotic induction effect of ALG-2. My studies also indicate that
there should be other mechanisms that activate ESCRT function of ALIX in cytokinetic
abscission and retroviral budding.
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Further exploration demonstrate that ALIX is phosphorylated at the S718 and
S721 residues, which locate at or near one of the intramolecular interaction sites,
during mitotic entry and that this phosphorylation relieves the intramolecular interaction
of ALIX in mitotic cells. This activating phosphorylation is required for inducing ALIX in
open conformation that recruits CHMP4 to the midbody area and therefore essential for
ALIX to support cytokinetic abscission. This activating phosphorylation also induces
ALIX in open conformation that interacts with retroviral Gag proteins and therefore
supports ALIX function in retroviral budding. In contrast, this phosphorylation is not
important for MVB sorting function of ALIX. These findings provide a new
understanding for the regulation of cytokinesis and retroviral budding and may provide
new strategies for inhibiting cell division and retroviral budding.
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Chapter 2: ALIX plays an essential role in MVB sorting of activated EGFR

Contents of this chapter are based on Sun, S., Zhou, X., Zhang, W., Gallick, G.E.,
Kuang, J. Unravelling the pivotal role of Alix in MVB sorting and silencing of the
activated EGFR. Biochem J. 2015;466(3):475-87. doi: 10.1042/BJ20141156.

Copyright permission is not required. Portland Press policy states “As long as the
original article, or portion of the article, is properly cited, and a link to the article is
included, Authors retain the following non-exclusive rights: To include their article in
whole or in part in their own dissertation or thesis in print or electronic format provided
that the full-text article is not then shared in an open repository unless it is published via
the Gold Open Access route.”

Background

EGFR is the model molecule for the study of ubiquitination-dependent
endolysosomal trafficking of membrane receptors. EGF binding to plasma membrane
EGFR induces the activation of EGFR, which is phosphorylated and ubiquitinated. The
activated EGFR is internalized into cytoplasm through endocytosis and during this
process, activated EGFR keeps on sending signals to its downstream pathways, such
as ERK1/2. Then, the internalized EGFR is sorted into the ILVs of MVBs through MVB
sorting. MVB sorting of activated EGFR is involved in timely terminating the signaling
function of activated EGFR and delivering EGFR to lysosome for degradation
(Gruenberg and Stenmark, 2004; Katzmann et al., 2002; Wegner et al., 2011).
MVB sorting of activated EGFR is performed by ESCRTs and their associated
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proteins. The ubiquitinated receptors are recognized and clustered by ESCRTs -0, -I,
and -II. ESCRT-0 binds ubiquitinated receptors through both subunits, Hrs (HGFregulated tyrosine kinase substrate) and STAM1/2. ESCRT-I subunit TSG101 and
ESCRT-II subunit hMvb12 are able to bind ubiquitinated receptors through their
ubiquitin binding domain (UBD). The coordination of receptors recognition and
membrane remodeling is achieved by the ability of ESCRT-II to both recognize the
ubiquitinated receptors and initiate the assembly of highly oligomerized ESCRT-III
complex. ESCRT-III subunit CHMP4 assembles into highly flexible filament that forms
spirals at the surface of endosome membranes. CHMP4 spirals can deform under
lateral compression and the relaxation of compressed CHMP4 spirals induces
membrane deformation. Thus, ESCRT-III is the core machinery that performs the
membrane scission at the budding site. ESCRT-III is timely disassembled by Vps4
(Henne et al., 2011; Henne et al., 2013; Hurley and Hanson, 2010; Lata et al., 2009).
Promoted by the previous reports that BRO1 plays a positive role in MVB sorting
of ubiquitinated receptors in yeast (Pashkova et al., 2013) and that ALIX contains
ubiquitin binding motifs, just as BRO1 does (Dowlatshahi et al., 2012; Pashkova et al.,
2013), I hypothesized that ALIX may be critically involved in MVB sorting of activated
EGFR in mammalian cells.
To test this hypothesis, I comprehensively study the role of ALIX in binding, MVB
sorting, silencing and degradation of activated EGFR in mammalian cell lines. The
results demonstrate that ALIX recognizes activated and ubiquitinated EGFR through its
V domain and plays an essential role in MVB sorting and silencing of activated EGFR.
However, ALIX does not have an essential role in lysosome-dependent degradation of
activated EGFR. These findings identify ALIX as an important regulator of the signaling
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output of activated EGFR and possibly other growth factor receptors.
Results
2.1.

ALIX interacts with activated and ubiquitinated EGFR through the V domain
To determine whether ALIX recognizes ubiquitinated EGFR, I ectopically

expressed GFP or GFP-ALIX in HEK293 cells, which were then mock-treated or
stimulated with EGF, and examined the GFP-ALIX interaction with EGFR by using coimmunoprecipitation (co-IP). Cell lysates were prepared from mock-treated and EGFstimulated cells with the membrane solubilizing lysis buffer containing 1% Triton X-100
in the presence or absence of the deubiquitinase inhibitor N-ethylmaleimide (NEM).
Cell lysates were immunoprecipitated with negative control mouse IgG or anti-GFP
antibody, and the immunocomplexes were immunoblotted to visualize EGFR,
ubiquitinated EGFR, GFP-ALIX and CHMP4B. As shown in Fig. 6A-B, in the presence
of NEM, EGF stimulation increased the association of GFP-ALIX with EGFR by ~4 fold,
and the ubiquitination of EGFR was confirmed by immunoblotting with anti-ubiquitin
antibodies. However, in the absence of NEM, there is only basal level of association of
GFP-ALIX with non-ubiquitinated EGFR, even with EGF stimulation. In contrast, the
association of GFP-ALIX with CHMP4B had no change under all conditions. In contrast
to GFP-ALIX, ectopically expressed GFP did not interact with EGFR, demonstrating
that the association of GFP-ALIX with EGFR is a specific event (Fig. 6C). These
results identify two modes of interaction between ALIX and EGFR: a high level of EGFinduced and ubiquitination-dependent interaction and a low level of constitutive
interaction.
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Figure 6. ALIX interacts with activated and ubiquitinated EGFR. (A&B) HEK293
cells were transfected with GFP-ALIX, serum starved for 12 h and stimulated with 100
ng/ml EGF for indicated minutes. Crude cell lysates were extracted in the presence or
absence of NEM.

(A) These cell lysates were directly immunoblotted to visualize

EGFR, GFP-ALIX and CHMP4B. (B) These cell lysates were immunoprecipitated with
anti-GFP antibody or mouse IgG followed by immunoblotting to visualize EGFR,
ubiquitinated EGFR, GFP-ALIX and CHMP4b. Results represent two independent
experiments. (C) HEK293 cells were transfected with GFP or GFP-ALIX, serum starved
for 12 h and stimulated with 100 ng/ml EGF for indicated minutes. Crude cell lysates
were prepared in the presence or absence of NEM and immunoprecipitated with antiGFP antibody. Input cell lysates and immunocomplexes were immunoblotted with
indicated antibodies to visualize GFP, GFP-ALIX, EGFR and ubiquitinated EGFR.
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To identify which domain of ALIX is responsible for ALIX interaction with EGFR,
HEK293 cells were transfected with FLAG-ALIXBro1 or HA-ALIXV, and co-IP was
performed to examine their interactions with EGFR. Cell lysates were prepared from
mock-treated and EGF-stimulated cells with the membrane solubilizing lysis buffer in
the presence of NEM. As shown in Fig. 7A, FLAG-ALIXBro1 only had low level of
constitutive interaction with EGFR irrespective of EGF stimulation. In contrast, HAALIXV had a high level of interaction with ubiquitinated EGFR in EGF-stimulated cells
(Fig. 7B). These results indicate that ALIXBro1 is responsible for constitutive ALIX
interaction with EGFR and that ALIXV is responsible for EGF-induced and
ubiquitination-dependent ALIX interaction with EGFR. The membrane proteins from
mock-treated or EGF-stimulated HEK293 cells were then extracted in the presence of
NEM and GST pull-down was performed by using GST-ALIXBro1 or GST-ALIXV to
examine their interactions with membrane-associated EGFR. As shown in Fig. 7C and
Fig. 7D, although GST-ALIXBro1 could not pull down detectable EGFR, GST-ALIXV
preferentially pulled down EGFR from EGF-stimulated cells. These results further
support the conclusion that ALIXV mediates ALIX interaction with ubiquitinated EGFR in
EGF-stimulated cells.

25

Figure 7. ALIX V domain interacts with activated and ubiquitinated EGFR. (A&B)
HEK293 cells were transfected with FLAG-ALIXBro1 (A) or HA-ALIXV (B) and stimulated
with 100 ng/ml EGF for indicated minutes. Cell lysates were prepared in the presence
of NEM and immunoprecipitated with anti-FLAG antibody and mouse IgG (A) or antiHA antibody and mouse IgG (B). Cell lysates and immunocomplexes were
immunoblotted to visualize EGFR and FLAG-ALIXBro1 in (A) or EGFR, ubiquitinated
EGFR, and HA-ALIXV in (B). (C&D) Membrane proteins from HEK293 cells stimulated
with 100 ng/ml EGF for indicated minutes were isolated and solubilized in the presence
of NEM and incubated with immobilized GST and GST-ALIXBro1 in (C) or GST and
GST-ALIXV in (D). Input and bound membrane proteins were immunoblotted to
visualize EGFR, GST and GST-ALIXBro1 in (C) or EGFR, GST and GST-ALIXV in (D).
Results represent two independent experiments.
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2.2.

EGF-induced EGFR activation promotes ALIX interaction with membrane-

bound CHMP4
ALIX involvement in all ESCRT-mediated processes requires ALIX interaction
with membrane-bound CHMP4. Thus, to define the role of ALIX in MVB sorting of
activated EGFR, I examined the interaction between ALIX and membrane-bound
CHMP4. To this end, I fractionated post-nuclear supernatant (PNS) from mock-treated
or EGF-stimulated HEK293 cells by using membrane flotation centrifugation. This
established method utilized sucrose gradients (73%, 65% and 10%) to separate
membrane vesicles (M) from soluble proteins (S) based on the density of membrane
vesicles (Ono and Freed, 1999; Spearman et al., 1997). After ultracentrifugation, the
membrane vesicles float at the interface between the layer of 65% sucrose and the
layer of 10% sucrose, while the soluble proteins stay at the bottom. As shown in Fig.
8A, in mock-treated cells, ~13% of endogenous ALIX was membrane associated, and
EGF stimulation increased the percentage of membrane associated ALIX to ~33%.
Ectopically expressing wild type (WT) GFP-ALIX had the similar distribution as
endogenous ALIX between M and S fraction in mock-treated and EGF-stimulated cells
(Fig. 8B). However, only ~3% of CHMP4 interaction-defective mutant I212D GFP-ALIX
associated with membrane in either mock-treated cells or EGF-stimulated cells (Fig.
8B). These results demonstrate that EGF-induced EGFR activation promotes ALIX
interaction with membrane bound CHMP4.
ALIX can dimerize through the V domain in an antiparallel manner. This
dimerization has been shown to promote assembly of CHMP4 filaments in vitro and be
required for ALIX to support ESCRT-III-mediated retroviral budding (Pires et al., 2009).
To determine whether membrane associated ALIX can dimerize through its V domain, I
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first examined the dimerization of ALIX in whole cell lysates from HEK293 cells
transfected with GFP-ALIX by using co-IP. The 1A3 anti-ALIX antibody, which
recognizes both ALIX and HD-PTP (Zhou et al., 2009), was used for immunoblotting of
input proteins and immunocomplexes. As shown in Fig. 8C, ectopically expressed
GFP-ALIX interacted with endogenous ALIX, but not with detectable level of
endogenous HD-PTP. I also performed co-IP of ectopically expressed GFP-ALIX and
FLAG-ALIX to further examine the dimerization of ALIX (Fig. 8D-E). The results from
this reciprocal co-IP further supported the conclusion. Together, these results
demonstrate that membrane-associated ALIX can form a dimer through the interaction
between the V domains.
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Figure 8. EGF-induced EGFR activation promotes ALIX interaction with
membrane-bound CHMP4. (A) HEK293 cells were serum starved for 12 h and either
mock-treated or stimulated with 100 ng/ml EGF for 1 h. The PNS was fractionated by
membrane flotation centrifugation and 10 fractions were taken by pipette for each
sample. The same volume of aliquot from each fraction was taken and immunoblotted
with indicated antibodies to visualize EEA1, ALIX and CHMP4b. (B) HEK293 cells were
transfected with WT or I212D GFP-ALIX and serum starved for 12 h before being
processed as described for (A). (C) HEK293 cells were transfected with GFP or GFP29

ALIX. Lysates of the transfected cells were immunoprecipitated with IgG or anti-GFP
antibody, and immunocomplexes were immunoblotted with indicated antibodies to
visualize GFP and GFP-ALIX (top panel) and endogenous ALIX, GFP-ALIX and
endogenous HD-PTP (lower panel). (D) HEK293 cells were transfected with FLAGALIX and either GFP or GFP-ALIX. The crude cell lysates were immunoprecipitated
with anti-GFP antibody or IgG. Input cell lysates and immunocomplexes were then
immunoblotted with indicated antibodies to visualize GFP, GFP-ALIX and FLAG-ALIX.
(D) HEK293 were transfected with GFP-ALIX and either FLAG or FLAG-ALIX. The
crude cell lysates were immunoprecipitated with anti-FLAG antibody or IgG. Input cell
lysates were immunocomplexes were then immunoblotted with indicated antibodies to
visualize GFP-ALIX and FLAG-ALIX.
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2.3.

ALIX plays a pivotal role in MVB sorting of activated EGFR
The previous results showing that ALIX binds activated and ubiquitinated EGFR

and that EGFR activation promotes ALIX association with membrane-bound CHMP4
generated a hypothesis that ALIX is positively involved in MVB sorting of activated
EGFR. To test this hypothesis, I first examined MVB sorting of activated EGFR by
using proteinase K protection assay, which involves isolation of intracellular membrane
vesicles after the plasma membrane is specifically dissolved by digitonin treatment.
The membrane vesicles were digested by proteinase K in the presence or absence of
0.1% Triton X-100. Since proteinase K cannot digest the EGFR that localizes within the
lumen of the intact endosome, the percentage of proteinase K-insensitive EGFR in the
absence of 0.1% Triton X-100 indicates the percentage of activated EGFR that is
sorted into ILVs of MVB (Dores et al., 2012a; Malerod et al., 2007). As shown in Fig. 9A,
after EGF stimulation for 30 min, the percentage of proteinase K-insensitive EGFR
increased from ~5% to ~60%. EEA1, which is the peripheral endosome membrane
protein, was used to demonstrate the efficient digestion by proteinase K.
To determine whether ALIX interaction with CHMP4 is required to support MVB
sorting of activated EGFR under EGF continuous stimulation condition, I transfected
HEK293 cells with FLAG-ALIXBro1 to compete with endogenous ALIX in binding CHMP4
and examined the effect on MVB sorting of activated EGFR. As shown in Fig. 9B,
ectopically expressing WT FLAG-ALIXBro1, but not I212D FLAG-ALIXBro1, dramatically
reduced the percentage of proteinase K-insensitive EGFR from ~60% to ~5%. The
results demonstrate that ALIX interaction with CHMP4 plays an essential role in MVB
sorting of activated EGFR.
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To determine whether V domain-mediated ALIX dimerization is required to
support MVB sorting of activated EGFR under EGF continuous stimulation condition, I
transfected HEK293 cells with HA-ALIXV to compete with endogenous ALIX in
dimerization and examined the effects on MVB sorting of activated EGFR. As shown in
Fig. 9C, ectopically expressing WT HA-ALIXV, but not dimerization mutated (DM) HAALIXV, dramatically reduced the percentage of proteinase K-insensitive EGFR from ~60%
to ~5%. Co-IP assay demonstrated that ectopically expressing WT HA-ALIXV interacts
with ALIX, but not HD-PTP, excluding the possibility that the inhibitory effects of WT
HA-ALIXV is due to the interaction with HD-PTP (Fig. 9D). The results demonstrate that
V domain-mediated ALIX dimerization is required for ALIX to support MVB sorting of
activated EGFR.
To further determine the role of ALIX in MVB sorting of activated EGFR under
EGF continuous stimulation condition, I transfected HEK293 cells with ALIX targeting
siRNA (si-ALIX) with or without co-expressing siRNA-insensitive GFP-ALIX (GFP-ALIX*)
and examined the effects on MVB sorting of activated EGFR. As shown in Fig. 9E,
knockdown of ALIX decreased the percentage of proteinase K-insensitive EGFR from
~50% to ~15%. While ectopic expression of WT GFP-ALIX* rescued the inhibitory
effects of ALIX knockdown, ectopic expression of I212D GFP-ALIX* or DM GFP-ALIX*
did not have this rescuing effect. These results further demonstrate that CHMP4-bound
ALIX dimer plays an essential role in MVB sorting of activated EGFR.
Multiple previous studies used EGF pulse-chase condition to study the role of
ALIX in degradation of activation of EGFR. Here, I examined the role of CHMP-4 bound
ALIX dimer in MVB sorting of activated EGFR under EGF pulse-chase condition.
Serum-starved cells were incubated with EGF at 4C for 30 min (EGF pulse) and then
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cultured at 37C in the absence of EGF (chase) for indicated lengths of time. As shown
in Fig. 9F, ectopic expression of WT HA-ALIXV or FLAG-ALIXBro1, or knockdown of
ALIX decreased percentage of protected EGFR from ~40% to <10% under EGF pulsechase condition.
Together, these results demonstrate that CHMP4-bound ALIX dimer plays an
essential role in MVB sorting of activated EGFR under both EGF continuous stimulation
condition and EGF pulse-chase condition.
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Figure 9. ALIX plays a pivotal role in MVB sorting of activated EGFR. (A) HEK 293
cells were mock-treated or EGF stimulated for 30 min. The proteinase K protection
assay was performed to determine the percentage of proteinase K-insensitive EGFR.
(B) HEK293 cells were transfected with FLAG, FLAG-ALIXBro1 or I212D FLAG-ALIXBro1.
The proteinase K protection assay was performed to determine the percentage of
proteinase K-insensitive EGFR. (C) HEK293 cells were transfected with HA, WT HAALIXV, or DM HA-ALIXV. The proteinase K protection assay was performed to
determine the percentage of proteinase K-insensitive EGFR. (D) HEK293 cells were
transfected with HA-ALIXV, and the cell lysates were immunoprecipitated with anti-HA
antibody or IgG. Input and immunocomplexes were immunoblotted with indicated
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antibodies to visualize endogenous ALIX, endogenous HD-PTP and HA-ALIXV. (E)
HEK293 cells were first transfected with si-NC or si-ALIX and cultured for 48 h. These
cells were then transfected with constructs for indicated proteins and cultured for
another 24 h. The proteinase K protection assay was performed to determine the
percentage of proteinase K-insensitive EGFR. (F) HEK293 cells were transfected as
indicated and stimulated with 100 ng/ml EGF under pulse-chase condition. The
proteinase K protection assay was performed to determine the percentage of
proteinase K-insensitive EGFR.
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2.4.

ALIX plays an important role in terminating the downstream signaling of

activated EGFR
ERK1/2 is the major downstream signaling of activated EGFR, and EGF-induced
ERK1/2 activation is a highly transient event (Xu et al., 2012), due to the rapid silencing
of activated EGFR by MVB sorting and the dephosphorylation by phosphatase.
To further support the conclusion that ALIX plays an essential role in MVB
sorting of activated EGFR, I examined the roles of ALIX interaction with membranebound CHMP4 in terminating the downstream signaling of activated EGFR. For this
purpose, HEK293 cells were transfected with Y319F FLAG-ALIXBro1 and the effects on
the kinetics of EGF-induced ERK1/2 activation were examined under EGF continuous
stimulation condition. The construct contains Y319F mutation to eliminate its interaction
with Src (Schmidt et al., 2005). As shown in Fig. 10A, under EGF continuous
stimulation condition, ERK1/2 activation was highly transient in mock-transfected cells,
reaching to the peak level at 10 min and then decreasing dramatically to the basal level
at 30 min. The ERK1/2 activation continued decreasing afterward to nearly
undetectable level from 1 h to 3 h. In contrast, ectopic expression of Y319F FLAGALIXBro1 inhibited the decrease of ERK1/2 activation and prolonged the duration of
ERK1/2 activation up to 3 h.
To determine whether V domain-mediated ALIX dimerization plays an important
role in terminating the downstream signaling of activated EGFR, HEK293 cells were
transfected with HA-ALIXV and the effects on the kinetics of EGF-induced ERK1/2
activation were examined under EGF continuous stimulation condition. Similar to the
ectopic expression of Y319F FLAG-ALIXBro1, ectopic expression of HA-ALIXV also
prolonged the duration of ERK1/2 activation up to 3 h (Fig. 10B).
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To further determine the role of ALIX in terminating the downstream signaling of
activated EGFR, HEK293 cells were transfected with control siRNA or si-ALIX and the
effects on the kinetics of EGF-induced ERK1/2 activation were examined under EGF
continuous stimulation condition. Similarly, knockdown of ALIX prolonged the duration
of ERK1/2 activation up to 3 h (Fig. 10C).
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Figure 10. ALIX plays an important role in terminating the downstream signaling
of activated EGFR under EGF continuous stimulation condition. (A) HEK293 cells
were transfected with FLAG or Y319F FLAG-ALIXBro1 and were stimulated with 100
ng/ml EGF for indicated minutes (left panel) or hours (right panel). Cell lysates were
immunoblotted with indicated antibodies to visualize phosphorylated ERK1/2 (pERK1/2), ERK1/2, FLAG-ALIXBro1 and actin. (B) HEK293 cells were transfected with
HA or HA-ALIXV and were stimulated with 100 ng/ml EGF for indicated minutes (left
panel) or hours (right panel). Cell lysates were immunoblotted with indicated antibodies
to visualize p-ERK1/2, ERK1/2, HA-ALIXV and actin. (C) HEK293 cells were transfected
with indicated siRNAs and stimulated with 100 ng/ml EGF for indicated minutes (left
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panel) or hours (right panel). Cell lysates were immunoblotted with indicated antibodies
to visualize p-ERK1/2, ERK1/2, ALIX and actin.
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Then, I further determined whether ALIX plays an important role in terminating
the downstream signaling of activated EGFR under EGF pulse-chase condition. Similar
to the results obtained under EGF continuous stimulation condition, EGF-induced
ERK1/2 activation decreased to nearly undetectable level from 1 h to 3 h. Ectopic
expression of FLAG-ALIXBro1 or HA-ALIXV, or transfection of si-ALIX inhibited the
decrease and prolonged the duration of ERK1/2 activation up to 3 h (Fig. 11A-C).
Together, these results demonstrate that CHMP4-bound ALIX dimer plays an
important role in rapidly terminating the downstream signaling of activated EGFR under
both EGF continuous stimulation and pulse-chase conditions and further support the
essential role of CHMP4-bound ALIX dimer in MVB sorting of activated EGFR.
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Figure 11. ALIX plays an important role in terminating the downstream signaling
of activated EGFR under EGF pulse-chase condition. (A) HEK293 cells were
transfected with FLAG or Y319F FLAG-ALIXBro1 and stimulated with 100 ng/ml EGF for
30 min (pulse) followed by incubation for indicated hours (chase). Cell lysates were
immunoblotted with indicated antibodies to visualize p-ERK1/2, ERK1/2, FLAG-ALIXBro1
and actin. (B) HEK293 cells were transfected with HA or HA-ALIXV and stimulated with
100 ng/ml EGF for 30 min (pulse) followed by incubation for indicated hours (chase).
Cell lysates were immunoblotted with indicated antibodies to visualize p-ERK1/2,
ERK1/2, HA-ALIXV and actin. (C) HEK293 cells were transfected with indicated siRNAs
and stimulated with 100 ng/ml EGF for 30 min (pulse) followed by incubation for
indicated hours (chase). Cell lysates were immunoblotted with indicated antibodies to
visualize p-ERK1/2, ERK1/2, ALIX and actin.
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2.5.

Depleting the CHMP4-bound ALIX dimer retards EGF-induced degradation

of activated EGFR
To determine whether ALIX-supported MVB sorting is required for EGF-induced
degradation of activated EGFR, I examined the effects of depleting CHMP4-bound
ALIX dimer on the kinetics of EGF-induced EGFR degradation under both EGF
continuous stimulation and EGF pulse-chase conditions.
To determine whether ALIX interaction with membrane-bound CHMP4 plays a
role in degradation of activated EGFR under EGF continuous stimulation condition,
HEK293 cells were transfected with FLAG, Y319F FLAG-ALIXBro1 or Y319F-I212D
FLAG-ALIXBro1 and stimulated with EGF for different time points. EGF stimulation
induced progressive reduction in EGFR protein level in mock-transfected and Y319FI212D FLAG-ALIXBro1 transfected cells. In contrast, ectopic expression of Y319F FLAGALIXBro1 inhibited EGFR degradation and increased the percentages of remaining
EGFR at 1, 2, 3 and 4 h (Fig. 12A).
To determine whether V domain-mediated ALIX dimerization plays a role in the
degradation of activated EGFR under EGF continuous stimulation condition, HEK293
cells were transfected with HA, WT HA-ALIXV or DM HA-ALIXV and stimulated with
EGF for different time points. Similar to the results of ectopic expression of FLAGALIXBro1, ectopic expression of WT HA-ALIXV, but not DM HA-ALIXV, increased the
percentages of remaining EGFR at 30 min, 1, 2, 3 and 4 h (Fig. 12B).
To further determine the role of CHMP-4 bound ALIX dimer in the degradation of
activated EGFR under EGF continuous stimulation condition, HEK293 cells were
transfected with si-ALIX with or without co-transfection of indicated forms of GFP-ALIX*
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and the effects on degradation of activated EGFR were examined. As shown in Fig.
12C-E, EGF continuous stimulation induced a progressive reduction in EGFR protein
level in mock-transfected cells. In contrast, knockdown of ALIX increased the
percentages of remaining EGFR at 1, 2, 3 and 4 h. Although ectopic expression of WT
GFP-ALIX* could rescue the effects of ALIX knockdown, ectopic expression of I212D
GFP-ALIX* or DM GFP-ALIX* did not have the rescuing effects.
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Figure 12. Depletion of the CHMP4-bound ALIX dimer retards EGF-induced
degradation of activated EGFR under EGF continuous stimulation condition. (A)
HEK293 cells were transfected with FLAG and indicated forms of FLAG-ALIXBro1 and
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stimulated with 100 ng/ml EGF for indicated hours. Cell lysates were immunoblotted
with indicated antibodies to visualize EGFR, FLAG-ALIXBro1 and actin. (B) HEK293
cells were transfected with HA and indicated forms of HA-ALIXV expressing cells and
stimulated with 100 ng/ml EGF for indicated hours. Cell lysates were immunoblotted
with indicated antibodies to visualize EGFR, HA-ALIXV and actin. (C-E) HEK293 cells
transfected with indicated siRNA and indicated siRNA-insensitive constructs were
stimulated with 100 ng/ml EGF for indicated hours. Cell lysates were immunoblotted
with indicated antibodies to visualize EGFR, ALIX, GFP-ALIX and actin.
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To determine the role of CHMP4-bound ALIX dimer in the degradation of
activated EGFR under EGF pulse-chase condition, the effects of ectopic expression of
Y319F FLAG-ALIXBo1 or HA-ALIXV or knockdown of ALIX on degradation of activated
EGFR were examined. As shown in Fig. 13, EGF pulse-chase stimulation induced a
progressive reduction in EGFR protein level in mock-transfected cells. Ectopic
expression of Y319F FLAG-ALIXBo1 or HA-ALIXV increased the percentages of
remaining EGFR at 1 and 2 h. Knockdown of ALIX only increased the percentage of
remaining EGFR at 1 h.
All these results demonstrate that ALIX-supported MVB sorting of activated
EGFR is not essential for trafficking of activated EGFR to lysosomes for degradation.

46

Figure 13. Depletion of the CHMP4-bound ALIX dimer retards EGF-induced
degradation of activated EGFR under EGF pulse-chase condition. (A) HEK293
cells were mock-transfected or transfected with Y319F FLAG-ALIXBro1 or HA-ALIXV and
stimulated with 100 ng/ml EGF for 30 min (pulse) followed by incubation for indicated
hours (chase). Cell lysates were immunoblotted with indicated antibodies to visualize
EGFR, FLAG-ALIXBro1 HA-ALIXV and actin. (B) HEK293 cells were transfected with
indicated siRNAs and stimulated with 100 ng/ml EGF for 30 min (pulse) followed by
incubation for indicated hours (chase). Cell lysates were immunoblotted with indicated
antibodies to visualize EGFR, ALIX and actin.
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Discussion
Although my current study clearly demonstrate that the CHMP4-bound ALIX
dimer plays an essential role in MVB sorting and silencing of activated EGFR under
both EGF continuous stimulation and pulse-chase conditions, multiple previous studies
led to a widely held notion that ALIX is not critically involved in ESCRT-mediated MVB
sorting of ubiquitinated receptors due to the obtained negative results that ALIX
knockdown had no or only a minor inhibitory effect on trafficking of activated EGFR to
lysosomes for degradation under the EGF pulse-chase stimulation condition (Bowers et
al., 2006; Cabezas et al., 2005; Doyotte et al., 2008; Schmidt et al., 2004). In this study,
I demonstrate the validity of the previous observations that ALIX is not essential for
lysosome-dependent degradation of activated EGFR. However, the previous studies
did not directly examine the effects of ALIX knockdown on MVB sorting of activated
EGFR; instead, they used lysosome-dependent degradation of activated EGFR as the
indicator of MVB sorting because of a widely held notion that MVB sorting is required
for trafficking activated EGFR to lysosome for degradation. However, multiple studies
showed that even the MVB sorting process is inhibited, cell surface receptors can still
be delivered to lysosome for degradation, although at a slower rate (Futter et al., 2001;
White et al., 2006). These studies, together with my current studies, support a logical
explanation that trafficking of activated EGFR to lysosomes for degradation in
mammalian cells can be achieved through both MVB sorting-dependent and independent mechanism and that ALIX is only involved in the MVB sorting-dependent
mechanism.
Although MVB sorting is not required for trafficking of activated EGFR to
lysosome for degradation in mammalian cells, it can work with a tyrosine phosphatase
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to terminate the downstream signaling of activated EGFR much earlier than EGFR
degradation. My results show that under both EGF continuous and pulse-chase
stimulation conditions, inhibition of the ALIX-supported MVB sorting of activated EGFR
prolong the duration of EGF-induced activation of ERK1/2 from <20 min to >2 h. These
results indicate that ALIX-supported MVB sorting is one of the major players in rapidly
silencing the signaling function of activated EGFR and predict that cells may regulate
the signaling output of activated EGFR or possibly other receptor tyrosine kinases
through regulating whether activated receptor is degraded through MVB sorting
pathway or the alternative pathway.
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Chapter 3: The mechanism that activates ESCRT function of ALIX in MVB sorting
of activated EGFR

Contents of this chapter are based on Sun, S., Zhou, X., Corvera, J., Gallick, G.E., Lin,
S., Kuang, J. ALG-2 activates the MVB sorting function of ALIX through relieving its
intramolecular interaction. Cell Discovery 2015; 1,15018. doi:10.1038/celldisc.2015.18

Copyright permission is not required. Nature Publishing Group policy states “You may
reuse this material without obtaining permission from Nature Publishing Group,
providing that the author and the original source of publication are fully acknowledged,
as per the terms of the license.”

Background

The studies from the previous chapter demonstrate the essential role of ALIX in
ESCRT-mediated MVB sorting of activated EGFR. ALIX involvement in ESCRTmediated processes requires ALIX interaction with CHMP4. However, the native form
of ALIX contains a default intramolecular interaction, which renders a closed
conformation of ALIX and prohibits ALIX interaction with CHMP4 (Zhou et al., 2009;
Zhou et al., 2010). This predicts that ALIX involvement in ESCRT-mediated processes
requires an activation step that relieves the intramolecular interaction of ALIX.
ALG-2 was originally identified through a functional screen of genes critical for Tcell receptor (TCR)-induced programmed cell death in T cell hybridoma (Vito et al.,
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1996). ALG-2 is a 22 kDa calcium-binding protein that interacts with ALIX in a calciumdependent manner (Missotten et al., 1999; Vito et al., 1999). ALG-2 possesses two
high-affinity calcium-binding sites (Lo et al., 1999) and mutation of the Glu47 and Glu114
residues to Ala (E47A/E114A) within both calcium-binding sites completely disrupts the
calcium-binding capacity of ALG-2 (Lo et al., 1999). Calcium binding induces
conformational change of ALG-2 and enables ALG-2 to bind four consecutive PxY
motifs (PPYPTYPGYPGY at 802-813) near the C-terminus of ALIX (Missotten
MTrioulier et al., 2004; Shibata et al., 2004). There is a spliced form of ALG-2, named
as ALG-2.1, which lacks the amino acid residues Gly121 and Phe122. Although ALG-2.1
is still able to bind to calcium, it cannot interact with ALIX (Marsh and McMahon, 1999).
The ALG-2 binding region in ALIX (802-813) is outside the region that forms
intramolecular interaction (1-746). Thus, the intramolecular interaction of ALIX should
not block ALIX interaction with ALG-2. Indeed, ALG-2 has been shown to be able to
bind native form of recombinant ALIX in a calcium-dependent manner (Missotten et al.,
1999; Vito et al., 1999). Moreover, inhibiting ALX interaction with ALG-2 by ectopic
expression of a C-terminal fragment of ALIX or mutation of the ALG-2 binding site in
ALIX attenuated the ability of ALIX in apoptotic induction (Mahul-Mellier et al., 2006;
Mahul-Mellier et al., 2008), indicating that ALG-2 may be the regulator of the functions
of ALIX. Due to its characteristics of calcium-binding, ALG-2 belongs to calmodulin
superfamily, and the calmodulin has been demonstrated to regulate the conformational
change of its partner proteins through relieving the intramolecular interaction of these
partner proteins (Hoffman et al., 2011), indicating that ALG-2 may be able to regulate
ALIX through similar mechanisms. Endocytosis of activated receptor tyrosine kinases,
which precedes MVB sorting, induces a rapid increase of calcium concentration in the
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vicinity of endosome (Gerasimenko et al., 1998; Gerasimenko and Tepikin, 2005),
indicating that internalization of activated EGFR may be linked to ALG-2 conformational
change and its interaction with ALIX. Moreover, the studies from the previous graduate
student in our group, Xi Zhou, showed that knockdown of ALG-2 retarded degradation
of ectopically expressed EGFR in HEK293 cells.
All these observations predict that calcium-dependent ALG-2 interaction with
ALIX may be one of the mechanisms by which the intramolecular interaction of ALIX is
relieved and the ESCRT functions of ALIX are activated. The preliminary data from the
previous graduate student in our group also indicated that calcium-dependent ALG-2
interaction with ALIX may induce the open conformation of ALIX. To further test this
prediction, a series of conformation-sensitive and -insensitive anti-ALIX monoclonal
antibodies, which were produced in our previous studies (Zhou et al., 2009; Zhou et al.,
2008), were used to examine the conformational change of ALIX. Conformationsensitive anti-ALIX antibodies 1A3 and 2H12 recognize Patch 2/Src binding site and
F676 pocket/Viral Gag binding site, respectively. In contrast, conformation-insensitive
anti-ALIX antibodies 1A12 and 3A9 recognize the epitope in the V domain that is not
blocked by intramolecular interaction. Thus, the 1A3 and 2H12 antibodies only
immunoprecipitate ALIX in its open conformation; the 1A12 and 3A9 antibodies
immunoprecipitate ALIX in both open and closed conformations.
My study demonstrates that calcium-dependent ALG-2 interaction with ALIX
relieves the intramolecular interaction of ALIX and specifically activates the MVB
sorting function of ALIX.

Results
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3.1.

Calcium-dependent ALG-2 interaction with ALIX transforms ALIX from

closed conformation to open conformation
I first verified the calcium-dependent ALG-2 interaction with ALIX in our
experimental system by using GST pull-down. In the presence of 10 µM CaCl2 but
absence of EGTA, GST-ALG-2 pulled down ALIX from HEK293 cytosolic proteins
prepared without detergent. In the presence of EGTA but absence of CaCl2, GST-ALG2 did not pull down detectable level of ALIX. In the absence of CaCl2 and EGTA, GSTALG-2 still pulled down detectable level of ALIX, although the level is much less than
that in the presence of CaCl2, possibly due to the endogenous calcium in the cytosolic
protein lysate (Fig. 14A). I also verified that WT GST-ALG-2, but not E47A/E114A (Mut)
GST-ALG-2, pulled down ALIX from HEK293 cytosolic proteins in the presence of 10
µM CaCl2 (Fig. 14B).
To determine whether calcium-dependent ALG-2 interaction with ALIX relieves
the intramolecular interaction of ALIX, I added GST or GST-ALG-2 to the cytosolic
fraction of HEK293 cells and immunoprecipitated ALIX with the 2H12 or 1A12
antibodies in the absence of detergent. Due to the background level of calcium in the
cytosolic fraction, which may activate a small portion of GST-ALG-2, the 2H12 antibody
immunoprecipitated a low level of ALIX from cytosolic fraction incubated with GSTALG-2. As a positive control, the 1A12 antibody immunoprecipitated similar level of
ALIX from cytosolic fraction incubated with GST or GST-ALG-2 (Fig. 14C).
Since the intramolecular interaction of ALIX prohibits ALIX interaction with its
partner proteins, such as CHMP4 and TSG101, I further determined the effects of
calcium-dependent ALG-2 interaction with ALIX on the conformational change of ALIX
by examining the co-IP of ALIX and its partner proteins. For this purpose, I added
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noting, CaCl2, or CaCl2 plus GST-ALG-2 to the cytosolic fraction of HEK293 cells
ectopically expressing FLAG-CHMP4b or FLAG-TSG101 and immunoprecipitated
FLAG-CHMP4b or FLAG-TSG101 with an anti-FLAG antibody in the absence of
detergent. The results showed that cytosolic ALIX did not immunoprecipitate with
FLAG-CHMP4b or FLAG-TSG101 in control cells. In the presence of CaCl2, detectable
level of ALIX was immunoprecipitated with FLAG-CHMP4b or FLAG-TSG101. In the
presence of CaCl2 and GST-ALG-2, much higher level of ALIX was immunoprecipitated
with FLAG-CHMP4b or FLAG-TSG101 (Fig. 14D-E). These results demonstrate that
calcium-dependent ALG-2 interaction with cytosolic ALIX relieves the intramolecular
interaction of ALIX and transforms ALIX from closed conformation to open
conformation.
To determine whether ALG-2-induced open formation of ALIX is reversible, I first
induced the open conformation ALIX by adding CaCl2 plus GST-ALG-2 to cytosolic
fractions of HEK293 cells and then dissociated GST-ALG-2 by adding EGTA to
cytosolic fractions of the cells. As shown in Fig. 14F-G, adding CaCl2 plus GST-ALG-2
relieved the intramolecular interaction of cytosolic ALIX, as demonstrated by
immunoprecipitation with the 1A3 antibody. Adding EGTA reversed the conformational
change of ALIX. However, if the cytosolic fractions contained ectopic expressing FLAGTSG101, GST-p6 or GST-p9 before adding EGTA, then EGTA treatment only partially
reversed the conformational change of ALIX. These results demonstrate that ALG-2induced conformational change of ALIX is a reversible event and that occupation by
partner proteins partially maintains the open conformation of ALIX.
Altogether, these results demonstrate that calcium-dependent ALG-2 interaction
with ALIX relieves the intramolecular interaction of ALIX and induces an open
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conformation of ALIX and that the open conformation of ALIX can be partially
maintained by newly recruited partner proteins after ALG-2 dissociation.
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Figure 14. Calcium-dependent ALG-2 interaction with ALIX transforms ALIX from
closed conformation to open conformation. (A&B) GST, WT GST-ALG-2 or Mut
GST-ALG-2 was immobilized onto GSH beads, which were then incubated with the
cytosolic fraction of HEK293 cell lysates containing CaCl2 or EGTA. Input proteins and
bound proteins were immunoblotted with indicated antibodies to visualize ALIX, GST
and GST-ALG-2. (C) GST or GST-ALG-2 was added into cytosolic proteins of HEK293
cells, which were then immunoprecipitated with indicated antibodies. Input and
immunocomplexes were immunoblotted with indicated antibodies to visualize ALIX,
GST and GST-ALG-2. (D&E) HEK293 cells were transfected with FLAG-CHMP4B (D)
or FLAG-TSG101 (E) and cytosolic proteins of the transfected cells were incubated
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with

CaCl2

or

CaCl2

plus

GST-ALG-2.

These

cytosolic

proteins

were

immunoprecipitated followed by immunoblotting with indicated antibodies. (F) GSTALG-2 plus CaCl2 and GST or GST-p6 were added into cytosolic proteins extracted
from HEK293 cells and incubated for 30 min. Then, the samples were treated with or
without EGTA for 30 min before being immunoprecipitated with the 1A3 antibody. Input
and immunocomplexes were immunoblotted with indicated antibodies to visualize ALIX,
GST-ALG-2 and GST-p6. (G) The assay was performed as described for (F), except
that GST-p6 was changed to GST-p9.
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3.2.

Calcium-dependent ALG-2 interaction with ALIX is essential for CHMP4-

dependent ALIX membrane association
I first determined whether ALIX association with the membrane is dependent on
interaction with CHMP4 by using membrane flotation centrifugation. HEK293 cells were
transfected with si-NC or a combination of two pairs of si-CHMP4B, and the distribution
of ALIX in M fraction was examined. As shown in Fig. 15A, transfection of si-CHMP4B
knocked down CHMP4B by ~70% and decreased the percentage of membrane
associated ALIX from ~13% to ~5%. EEA1 and actin were used as internal control for
membrane proteins and soluble proteins, respectively in order to eliminate the
possibility of contamination. The results demonstrate that ALIX association with the
membrane is dependent on CHMP4.
To determine the effects of calcium-dependent ALG-2 interaction with ALIX on
ALIX membrane association, HEK293 cells were transfected with FLAG or FLAG-ALG2 and the PNSs were fractionated by using membrane flotation centrifugation. If the
cells were briefly treated with calcium ionophore A23187 before collection, ectopic
expression of FLAG-ALG-2 increased the percentage of membrane associated ALIX
from ~11% to ~53%. However, ectopic expression of FLAG-ALG-2 alone did not
significantly increase the percentage of membrane associated ALIX (Fig. 15B-C).
These results demonstrate that calcium-dependent ALG-2 interaction with ALIX
promotes ALIX association with membrane.
To determine whether ALG-2-induced increase in ALIX membrane association is
dependent on CHMP4, HEK293 cells were co-transfected with FLAG-ALG-2 and WT,
I212D or ALG-2 binding site-deleted (∆PxY) GFP-ALIX and briefly treated with calcium
ionophore A23187 before collection. The results of membrane flotation centrifugation
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showed that ectopic expression of FLAG-ALG-2 in conjunction with a brief calcium
ionophore A23187 treatment increased WT GFP-ALIX membrane association similarly
as it did to the endogenous ALIX. However, I212D or ∆PxY mutation abolished GFPALIX membrane association (Fig. 15D). These results demonstrate that ALG-2-induced
ALIX association with membrane is dependent on ALIX interaction with CHMP4.
To further determine the role of ALG-2 in ALIX association with the membrane,
HEK293 cells were transfected with si-NC or si-ALG-2 and the effects on ALIX
association with the membrane was determined by membrane flotation centrifugation.
The results showed that knockdown of ALG-2 decreased the percentage of membrane
associated ALIX from ~13% to ~2-3%, suggesting that ALG-2 plays a physiological role
in ALIX association with membrane (Fig. 15E-F).
Altogether, these results demonstrate that Ca2+-dependent ALG-2 interaction
with ALIX plays a rate-limiting role in CHMP-4 dependent ALIX association with
membrane.
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Figure 15. Calcium-dependent ALG-2 interaction with ALIX is essential for
CHMP4-dependent ALIX membrane association. (A) HEK293 cells were transfected
with si-NC or si-CHMP4B. PNSs from the transfected cells were fractionated by
membrane flotation centrifugation. M and S protein fractions were immunoblotted to
visualize ALIX, CHMP4B, EEA1 and actin. (B) HEK293 cells were transfected with
FLAG or FLAG-ALG-2. PNSs were prepared from these transfected cells treated with
calcium ionophore A23187 and processed as described in (A). (C) HEK293 cells were
transfected with FLAG or FLAG-ALG-2. PNSs were prepared from these transfected
cells and processed as described in (A). (D) HEK293 cells were co-transfected with
FLAG or FLAG-ALG-2 and indicated forms of GFP-ALIX. PNSs were prepared from
these transfected cells treated with calcium ionophore A23187 and processed as
described in (A). (E-F) HEK293 cells were transfected with si-NC or si-ALG-2. PNSs
were prepared from these transfected cells processed as described in (A).
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3.3. EGF-induced EGFR activation increases ALIX association with the
membrane through promoting ALG-2 interaction with ALIX
To determine the effects of EGF-induced EGFR activation on ALIX and ALG-2
association with the membrane, HEK293 cells were stimulated with or without 100
ng/ml EGF for 1 h and PNSs were prepared for membrane flotation centrifugation. The
results showed that EGF stimulation not only increased the percentage of membraneassociated ALIX from ~12% to ~35%, but also increased the percentage of membraneassociated ALG-2 from ~11% to ~44%. In contrast, the even distribution of CHMP4B
between M fraction and S fraction was not changed (Fig. 16A).
To determine whether EGF stimulation promotes ALG-2 interaction with ALIX,
HEK293 cells were stimulated with or without EGF and the cell lysates were prepared
with 0.1% Triton X-100 to dissolve the membrane and 10 µM CaCl2. The results of coIP showed that EGF stimulation increased ALG-2 interaction with ALIX by ~3.5 fold
(Fig.16B).
Since ALG-2 interaction with ALIX is calcium-dependent and endocytosis of cell
surface receptors induces a spike of calcium near endosomes, I then determined
whether calcium is required for EGF-induced increase in ALIX association with the
membrane. For this purpose, HEK293 cells were mock-treated or treated with cell
permeable calcium chelator BAPTA-AM before EGF stimulation and the effects of
BAPTA-AM treatment on ALIX association with the membrane was examined. As
shown in Fig. 16C, BAPTA-AM treatment inhibited EGF-induced increase in ALIX
association with the membrane. All these results suggest that calcium-dependent ALG2 interaction with ALIX is required for EGF-induced increase of ALIX association with
the membrane.
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To further test this assumption, I knocked down endogenous ALG-2 or
overexpressed FLAG-ALG-2 in HEK293 cells and examined the effects on EGFinduced ALIX association with the membrane. As shown in Fig. 16D, knockdown of
ALG-2 decreased the percentages of membrane-associated ALIX to barely detectable
level in both mock-treated and EGF-stimulated cells. In contrast, overexpression of WT
FLAG-ALG-2, but not Mut FLAG-ALG-2, in EGF-stimulated cells increased the
percentage of membrane-associated ALIX from ~35% to ~53% (Fig. 16E-F). HEK293
cells were then transfected with WT GFP-ALIX, PxY GFP-ALIX or I212D GFP-ALIX
and then stimulated with or without EGF. The membrane association of GFP-ALIX was
determined by using membrane flotation centrifugation. As shown in Fig. 16G, EGF
stimulation increased the membrane association of WT GFP-ALIX. In contrast, PxY
GFP-ALIX or I212D GFP-ALIX was barely detectable. These results support our
assumption.
Altogether, these results demonstrate that EGF stimulation increases ALIX
association with the membrane through promoting Ca2+-dependent ALG-2 interaction
with ALIX.
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Figure 16. EGF-induced EGFR activation increases ALIX association with the
membrane through promoting ALG-2 interaction with ALIX. (A) Serum starved
HEK293 cells were stimulated with or without EGF for 1 h. PNSs were prepared for
membrane flotation centrifugation. (B) Serum starved HEK293 cells were stimulated
with or without EGF for 1 h. Cell lysates were prepared in the presence of 0.1% Triton
X-100 and 10 µM CaCl2 and immunoprecipitated with the 3A9 antibody. Input proteins
and immunocomplexes were immunoblotted to visualize ALIX and ALG-2. (C) Serum
starved HEK293 cells were treated with BAPTA-AM starting 1 h before EGF stimulation.
PNSs were prepared for membrane flotation centrifugation. (D) HEK293 cells were
transfected with si-ALG-2(1) and serum starved for 12 h before mock-treated or
stimulated with EGF for 1 h. PNSs were prepared for membrane flotation centrifugation.
(E&F) HEK293 cells were transfected with FLAG or WT FLAG-ALG-2 (E) or Mut FLAGALG-2 (F) and serum starved for 12 h before stimulated with EGF for 1 h. PNSs were
prepared for membrane flotation centrifugation. (G) HEK293 cells were transfected with
indicated forms of GFP-ALIX and serum starved for 12 h. These cells were stimulated
with or without EGF for 1 h. PNSs were prepared for membrane flotation centrifugation.
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3.4.

Membrane-associated ALIX is in an open conformation
To determine whether membrane-associated ALIX is in an open conformation,

M fraction and S fraction were fractionated by membrane floatation centrifugation and
the pooled M fraction proteins and pooled S fraction proteins were extracted with 0.1%
Triton X-100, which dissolves the membrane vesicles and preserves the intramolecular
interaction of ALIX, and then immunoprecipitated with anti-ALIX antibodies. 5×M
fraction proteins were used to make the total protein level is comparable to that of 1×S
fraction proteins. Although conformation-sensitive 1A3 antibody immunoprecipitated
ALIX from 5×M fraction, it did not immunoprecipitate ALIX from 1×S fraction. In contrast,
conformation-insensitive 3A9 antibody immunoprecipitated comparable levels of ALIX
from 5×M fraction and 1×S fraction (Fig. 17A).
To determine whether ALG-2-induced membrane-associated ALIX is in an open
conformation, PNSs of HEK293 cells ectopically expressing FLAG-ALG-2 and being
treated with calcium ionophore A23187 were fractionated by membrane flotation
centrifugation. Pooled M fraction and pooled S fraction proteins were extracted with 0.1%
Triton X-100 for co-IP with the 3A9 antibody. Although FLAG-ALG-2, TSG101 and
CHMP4B were co-immunoprecipitated with ALIX in M fraction, no detectable levels of
any of these three proteins were co-immunoprecipitated with ALIX in S fraction,
indicating that ALIX in M fraction of FLAG-ALG-2 expressing cells is in an open
conformation (Fig. 17B).
To determine whether EGF-induced membrane-associated ALIX is in an open
conformation, PNSs of HEK293 cells stimulated with EGF were fractionated by
membrane flotation centrifugation. 5×pooled M fraction and 1×pooled S fraction
proteins were extracted with 0.1% Triton X-100 for co-IP with the 3A9 antibody. The
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results showed that ALIX in M fraction, but not S fraction, was co-immunoprecipitated
with endogenous ALG-2 and CHMP4B (Fig. 17C).
Altogether, these results demonstrate that EGF-induced and ALG-2-dependent
membrane-associated ALIX is in an open conformation and interacts with partner
proteins.
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Figure 17. Membrane-associated ALIX is in an open conformation. (A) PNSs
extracted from HEK293 cells were fractionated by membrane flotation centrifugation.
5×volumes of M fractions were pooled and 1×volume of S fraction was pooled. These
pooled M and S fractions were immunoprecipitated with indicated antibodies. Input and
immunocomplexes were immunoblotted to visualize ALIX and IgG. (B) HEK293 cells
were transfected with FLAG-ALG-2. The transfected cells were treated with calcium
ionophore A23187 for 15 min before collection. PNSs were fractionated by membrane
flotation centrifugation. Pooled M fraction and S fractions were immunoprecipitated with
the 3A9 antibody. Input and immunocomplexes were immunoblotted to visualize ALIX,
FLAG-ALG-2, TSG101, and CHMP4B. (C) HEK293 cells were serum starved for 12 h
and then stimulated with or without EGF for 1 h. 5×volumes of M fractions were pooled
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and 1×volume of S fraction was pooled. These pooled M and S fractions were
immunoprecipitated with the 3A9 antibody. Input and immunocomplexes were
immunoblotted to visualize ALIX, ALG-2, and CHMP4B.
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3.5.

ALG-2-induced activation of ALIX plays an essential role in MVB sorting of

activated EGFR at early endosomes
The data demonstrating that calcium-dependent ALG-2 interaction with ALIX is
essential for EGF-induced ALIX association with membrane suggests that ALG-2 may
play an essential role in MVB sorting of activated EGFR. To test this hypothesis, I first
examined whether knockdown of ALG-2 affects MVB sorting of activated EGFR by
using proteinase K protection assay. HEK293 cells were first transfected with si-NC or
si-ALG-2 and then transfected with WT or Mut FLAG-ALG-2* and the effects on MVB
sorting of activated EGFR were examined. The results showed that knockdown of ALG2 decreased the percentage of the proteinase K-insensitive EGFR from ~60% to ~17%.
Ectopically expressing WT FLAG-ALG-2* rescued the percentage of the proteinase Kinsensitive EGFR to near control level. In contrast, ectopically expressing Mut FLAGALG-2* only slightly rescued the defect in MVB sorting of activated EGFR (Fig. 18A).
These results demonstrate that ALG-2 interaction with ALIX plays an essential role in
MVB sorting of activated EGFR.
To further test this hypothesis, HEK293 cells were first transfected with si-ALIX
and then transfected with WT or PxY GFP-ALIX* and the effects on MVB sorting of
activated EGFR were examined. Knockdown of ALIX decreased the percentage of the
proteinase K-insensitive EGFR from ~60% to ~14%. Ectopically expressing WT GFPALIX*, but not PxY GFP-ALIX*, rescued the defect in MVB sorting of activated EGFR
(Fig. 18B). These results support our conclusion.
I already demonstrated that ALIX-supported MVB sorting of activated EGFR is
essential for rapidly terminating the downstream signaling of activated EGFR. Thus, I
further examined the effects of ALG-2 on the kinetics of EGF-induced ERK1/2
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activation under EGF continuous stimulation condition. As shown in Fig. 18C, EGF
stimulation for 10 min induced the peak level of ERK1/2 activation and the activation of
ERK1/2 dramatically decreased to basal level after 30 min of EGF stimulation. The
level of ERK1/2 activation continued decreasing to nearly undetectable level from 1 h to
3 h of EGF stimulation. Knockdown of ALG-2 prevented the decrease of ERK1/2
activation in 1 h of EGF stimulation and promoted the sustained ERK1/2 activation from
1 h to 3 h of EGF stimulation. These results demonstrate that ALG-2 plays an important
role in regulating the downstream signaling of activated EGFR and also further support
our conclusion that ALG-2 is required for ALIX-supported MVB sorting of activated
EGFR.
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Figure 18. ALG-2-induced activation of ALIX plays an essential role in MVB
sorting of activated EGFR. (A) HEK293 cells were first transfected with si-NC or siALG-2 and then mock-transfected or transfected with indicated forms of FLAG-ALG-2*.
These cells were serum starved for 12 h and stimulated with EGF for 30 min before
being measured by the proteinase K protection assay. (B) HEK293 cells were first
transfected with si-NC or si-ALIX and then mock-transfected or transfected with
indicated forms of GFP-ALIX*. These cells were serum starved for 12 h and stimulated
with EGF for 30 min before being measured by the proteinase K protection assay.
(C&D) HEK293 cells were transfected with si-NC or si-ALG-2 and serum starved for 12
h before being stimulated with EGF for indicated minutes (C) or hours (D). Cell lysates
were immunoblotted to visualize p-ERK1/2, ERK1/2 and actin.

72

Since endocytosis of activated EGFR is prerequisite for MVB sorting of activated
EGFR, thus it is possible that the inhibitory effects of ALG-2 or ALIX knockdown on
MVB sorting of activated EGFR is from the inhibitory effects on endocytosis. To test
this possibility, I knocked down ALIX or ALG-2 in HEK293 cells and stimulated the
serum-starved cells with EGF for indicated time points. Then, the levels of cell surface
EGFR were examined by biotinylation of cell surface proteins followed by pull-down of
these biotynlated proteins by streptavidin beads. Immunoblotting with anti-EGFR
antibody showed that knockdown of ALIX only slightly decreased the percentage of cell
surface EGFR at the time point of 10 min (Fig. 19A). Knockdown of ALG-2 did not
affect the levels of cell surface EGFR before and after EGF stimulation (Fig. 19B).
These results eliminate the possibility that endocytosis of activated EGFR plays any
roles in ALG-2-ALIX-dependent MVB sorting of activated EGFR.
To determine whether ALG-2/ALIX regulates MVB sorting of activated EGFR at
early endosome or late endosome, I transfected HeLa cells with GFP-Rab5 (Q79L),
which generates enlarged early endosome that can be observed by fluorescent
microscope (Brankatschk et al., 2012; Raiborg et al., 2002), stimulated the serumstarved cells with EGF for 30 min and examined the localization of EGFR by using
immunostaining with an anti-EGFR antibody. In control knockdown cells, ~60% of
EGFR localized within the GFP-labelled early endosomes. Knockdown of ALIX or ALG2 decreased the percentage of intraluminal EGFR to ~20% (Fig. 19C). These results
support the role of ALG-2/ALIX in promoting MVB sorting of activated EGFR at early
endosomes.
To further test this conclusion, I treated HEK293 cells with microtubule poison
nocodazole to block early to late endosome trafficking (Abrami et al., 2004) and
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examined whether the inhibitory effects of ALG-2 knockdown on MVB sorting of
activated EGFR was affected. The results of proteinase K protection assay showed that
treatment with nocodazole did not affect the inhibitory effects of ALG-2 knockdown on
MVB sorting of activated EGFR (Fig. 19D), further supporting our conclusion.
Taken together, these results demonstrate that ALG-2 induced activation of
ALIX promotes MVB sorting of activated EGFR at early endosome.
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Figure 19. ALG-2/ALIX plays an essential role in MVB sorting of activated EGFR
at early endosome. (A&B) HEK293 cells were transfected with si-NC or si-ALIX (A) or
si-ALG-2 (B) and serum starved for 12 h before being stimulated with EGF for indicated
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minutes. These cells were biotinylated and cell lysates extracted from these cells were
incubated with streptavidin beads for pull-down of biotinylated cell surface proteins.
Input and bound proteins were immunoblotted to visualize EGFR, ALIX and actin. (C)
HeLa cells were first transfected with si-NC, si-ALIX or si-ALG-2 and then transfected
with GFP-Rab5 (Q79L) before serum starvation for 12 h. These cells were stimulated
with EGF for 30 min, fixed and stained with an anti-EGFR antibody (red). Total and
intra-luminal EGFR were scored for 10 GFP-labeled endosomes for each condition,
and the percentages of intra-luminal EGFR were determined. (D) HEK293 cells were
transfected with si-NC or si-ALG-2 and serum starved for 12 h. These cells were
treated with 10 µM nocodazole for 2 h before and during EGF stimulation before being
measured by proteinase K protection assay.
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3.6.

ALG-2-induced activation of ALIX plays an important role in EGF-induced

EGFR degradation
The results in the previous chapter showed that knockdown of ALIX inhibited
MVB sorting of activated EGFR and retarded the degradation of activated EGFR under
EGF continuous stimulation condition. Since ALG-2 is required for ALIX to support
MVB sorting of activated EGFR, I hypothesized that ALG-2-induced activation of ALIX
plays an important role in EGF-induced EGFR degradation under EGF continuous
stimulation condition. To test this hypothesis, I first knocked down ALG-2 and examined
the effects on the kinetics of EGF-induced EGFR degradation under EGF continuous
stimulation condition. As shown in Fig. 20A-B, knockdown of ALG-2 increased the
percentage of remaining EGFR at 1, 2, 3 and 4 h, resulting in retardation of the 50%
EGFR degradation from 1 h to 2-2.5 h. Ectopically expressing WT FLAG-ALG-2*, but
not Mut FLAG-ALG-2*, rescued the defect in EGFR degradation induced by knockdown
of ALG-2. Then, WT or Mut FLAG-ALG-2 was overexpressed in HEK293 cells and the
effect on EGF-induced EGFR degradation was examined. As shown in Fig. 20C,
overexpression of WT FLAG-ALG-2, but not Mut FLAG-ALG-2 decreased the
percentage of remaining EGFR at 1, 2 and 3 h, accelerating the 50% EGFR
degradation from 1 h to 0.5 h. To further test the hypothesis, I examined the rescuing
effects of WT or ∆PxY GFP-ALIX* on EGF-induced EGFR degradation in ALIX
knockdown cells. As shown in Fig. 12C and 20D, WT, but not ∆PxY GFP-ALIX*,
rescued the defect in EGFR degradation in ALIX knockdown cells.
Taken together, these results demonstrate that ALG-2 induced activation of
ALIX plays an important role in EGF-induced EGFR degradation under EGF continuous
stimulation condition.
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Figure 20. ALG-2-induced activation of ALIX plays an important role in EGFinduced EGFR degradation. (A&B) HEK293 cells were first transfected with si-NC or
si-ALG-2(1) and then transfected with WT FLAG-ALG-2* (A) or Mut FLAG-ALG-2* (B)
before being serum starved for 12 h. These cells were then stimulated with EGF for
indicated hours, and cell lysates were immunoblotted to visualize EGFR, ALG-2, FLAGALG-2 and actin. (C) HEK293 cells were transfected with WT FLAG-ALG-2 or Mut
FLAG-ALG-2 before being serum starved for 12 h. These cells were then stimulated
with EGF for indicated hours, and cell lysates were immunoblotted to visualize EGFR,
FLAG-ALG-2 and actin. (D) HEK293 cells were transfected with si-NC or si-ALIX(1)
and then transfected with ∆PxY GFP-ALIX* before being serum starved for 12 h. These
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cells were then stimulated with EGF for indicated hours, and cell lysates were
immunoblotted to visualize EGFR, ALIX, GFP-ALIX and actin.
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3.7.

ALG-2 is not required for supporting ALIX to function in cytokinetic

abscission or retroviral budding
Besides MVB sorting function, ALIX has been demonstrated to be critically
involved in cytokinetic abscission and retroviral budding. Since all these ESCRTmediated processes require relieving the intramolecular interaction of ALIX, I examined
whether ALG-2 is also required for supporting ALIX to function in cytokinetic abscission
and retroviral budding. First, I examined whether ALG-2 is required to support
cytokinetic abscission. The failure in cytokinetic abscission induces multinucleated cells
and midbody-stage cells. As a positive control, knockdown of ALIX in HeLa cells
increased the percentages of multinucleated and midbody-stage cells from ~5% to ~35%
(Fig. 21A), consistent with the previous studies (Carlton and Martin-Serrano, 2007;
Morita et al., 2007). In contrast, knockdown of ALG-2 did not significantly increase the
percentages of multinucleated and midbody-stage cells (Fig. 21A), suggesting that
ALG-2 is not important for cytokinetic abscission.
Then, I examined whether ALG-2 is required to support retroviral budding. For
this purpose, I first knocked down ALG-2 in HEK293 cells by using siRNA and then
transfected the cells with pEV53B-EIAVGAG. Virus-like particles (VLPs) were collected
from culture medium by ultracentrifugation. The levels of VLPs were examined by
immunoblotting of VLP lysates using anti-capsid (CA) antibodies. As a positive control,
knockdown of ALIX significantly inhibited EIAV budding from infected HEK293 cells
(Fig. 21B), consistent with the previous reports (Strack et al., 2003; von Schwedler et
al., 2003). In contrast, knockdown of ALG-2 did not inhibit EIAV budding (Fig. 21B),
suggesting that ALG-2 is not important for EIAV budding.
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Taken together, these results suggest that ALG-2 specifically generates
functional ALIX in MVB sorting of activated EGFR and that there should be other
mechanisms by which ALIX is activated to function in cytokinetic abscission and
retroviral budding.
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Figure 21. ALG-2 is not required for supporting ALIX to function in cytokinetic
abscission or retroviral budding. (A&B) HeLa cells were transfected with si-NC, siALIX or si-ALG-2, fixed and stained with anti-tubulin antibodies (red) and
counterstained with DAPI (blue). (A) Hollow arrows indicate multinucleated or midbodystage cells. Scale bar: 50 µm. (B) Average percentages of multinucleated and
midbody-stage cells and SDs for each condition were determined from three
independent experiments and plotted (lower panel). (C&D) HEK293 cells were first
transfected with si-NC, si-ALIX(1) or si-ALIX(2) (C) or with si-NC, si-ALG-2(1) or siALG-2(2) (D) and then transfected with EIAV pEV53B. Released VLPs were collected
by using ultracentrifugation. Cell lysates and VLPs were immunoblotted with anti-CA
antibodies.
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Discussion
Results from the previous chapter demonstrate the essential role of CHMP4bound ALIX dimer in MVB sorting and silencing of activated EGFR. However, the
default intramolecular interaction of ALIX inhibits MVB sorting function of ALIX through
prohibiting ALIX interaction with CHMP4. Here, my studies demonstrate that calciumdependent ALG-2 interaction with ALIX completely relieves the intramolecular
interaction of ALIX and promotes ALIX association with membrane-bound CHMP4.
Although this mechanism is essential for activating ESCRT function of ALIX in MVB
sorting of activated EGFR, it is not involved in activating ESCRT function of ALIX in
cytokinetic abscission and retroviral budding.
In default condition, only ~10%-15% of ALIX is membrane associated and this
membrane association is dependent on ALG-2, indicating that calcium is one of the
rate-limiting factors in this regulatory mechanism. However, treating cells with calcium
ionophore A23187 alone only slightly increased the level of ALIX in open conformation.
Combination of overexpressing ALG-2 and adding calcium ionophore A23187
significantly increased the level of ALIX in open conformation, indicating that ALG-2
availability is also the rate-limiting factor in this regulatory mechanism.
Activation of EGFR induces a calcium spike near endosomes (Gerasimenko et
al., 1998; Gerasimenko and Tepikin, 2005). Consistent with this, our results showed
that EGF stimulation promoted ALG-2 interaction with ALIX. However, there is possible
that EGFR activation also increases the availability of ALG-2. Although the underlining
mechanism is still unknown, I predict that EGFR activation may induce the
phosphorylation of ALG-2, which increases the availability of ALG-2. This prediction
needs to be examined in the future studies.
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ALG-2 was originally identified as apoptotic induction protein (Vito et al., 1996).
The studies exploring the mechanisms of the pro-apoptotic function of ALG-2 identified
ALIX as the ALG-2 interacting proteins and this interaction is essential for apoptotic
induction. The studies in this chapter lead us to hypothesize that ALG-2 may induce
apoptosis through terminating the downstream signaling of activated receptor tyrosine
kinases.

84

Chapter 4: The mechanism that activates ALIX function in cytokinetic abscission
and retroviral budding
The contents of this chapter are based on Sun, S., Sun, L., Zhou, X., Wu, C., Wang, R.,
Lin, S.H., Kuang, J. Phosphorylation-Dependent Activation of the ESCRT Function of
ALIX in Cytokinetic Abscission and Retroviral Budding. Dev Cell. 2016;36(3):331-43.
doi: 10.1016/j.devcel.2016.01.001.

Copyright permission is required and obtained from Cell Press (License No.:
3830440570477).

Background

The results from chapter 3 showing that ALG-2 is not important for ALIXmediated cytokinetic abscission or retroviral budding suggest that there should be other
mechanisms that activate ESCRT functions of ALIX in these two processes.
Cytokinesis initiates during early anaphase with a primary ingression of the
cleavage furrow mediated by contraction of the actomyosin ring. As furrowing
progresses, the spindle midzone, which is the structure formed during anaphase
between the separating chromosomes by overlapping spindle microtubules, transforms
into the intercellular bridge. Two daughter cells are connected by the intercellular
bridge, at the middle of which is a dense structure termed the midbody. The midbody
contains antiparallel arrays of microtubules that cross the Flemming body, which is the
electron-dense structure that forms at the center of the midbody when the spindle
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midzone’s microtubules are compacted after furrow ingression. The midbody provides
the anchorage to the ingressed cleavage furrow and the platform for the recruitment
and assembly of ESCRTs. Before abscission occurs, a secondary ingression forms and
decreases the thickness of the intercellular bridge from 1.5-2 µm to 100-200 nm
(Agromayor and Martin-Serrano, 2013; Mierzwa and Gerlich, 2014). During late
telophase, FIP3 endosomes deliver p50RhoGAP and SCAMP2/3 to the intercellular
bridge, where SCAMP2/3 and p50RhoGAP are involved in depolymerization of the
cortical actin. The depolymerization of the cortical actin is required for successful
completion of abscission. Knockdown of SCAMP2/3 or p50RhoGAP was shown to
significantly decrease the percentage of cells with secondary ingression. FIP3,
SCAM2/3 or p50RhoGAP was also shown to be required for ESCRT machinery to be
recruited to the abscission site to perform the final cut (Schiel et al., 2012).
Before cytokinetic abscission, Cep55 is recruited to the midbody through the
direct interaction between Cep55 and midbody component MKLP1 (mitotic kinesin-like
protein 1) (Bastos and Barr, 2010). Cep55 recruits ESCRT-associated protein ALIX to
the midbody through the direct interaction. ALIX in turn recruits ESCRT-III component
CHMP4 to the midbody area and promotes the assembly of 17-nm ESCRT-III filament.
Membrane abscission occurs ∼1 μm away from the midbody where the microtubules
are removed by microtubule-severing protein, spastin, enabling full constriction at the
abscission site. ESCRT-III filaments assemble at both the midbody and membrane
abscission site but appear to be discontinuous (Carlton et al., 2008; Guizetti et al., 2011;
Morita et al., 2007).
The budding of enveloped viruses away from the infected cells is the process in
which the membrane is distorted away from the cytoplasm and ultimately wrapped
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around the assembling viral particles followed by severing membrane connected the
viral particles and cells to release the viral particles (Martin-Serrano and Neil, 2011;
Votteler and Sundquist, 2013). Retroviral assembly and budding is driven primarily by
Gag, a polyprotein that contains all the necessary domains. Retroviruses hijack
ESCRTs in host cells through direct interaction between YPXL motif in L domain of
Gag protein and the F676 pocket in ALIX (Martin-Serrano and Neil, 2011; Strack et al.,
2003; von Schwedler et al., 2003; Votteler and Sundquist, 2013).
Previous studies of the Xenopus ortholog of ALIX, Xp95, during meiotic
maturation of Xenopus oocytes showed that Xp95 is phosphorylated both at the
conserved tyrosine residue (Y318) within the Patch 2 of the Bro1 domain (Dejournett et
al., 2007), and at multiple sites within N-terminal portion of PRD (nPRD) in M phasearrested mature oocytes (Dejournett et al., 2007). Alignment of the sequence of Xp95
and ALIX showed that most of the phosphorylation sites within the Bro1 domain and
nPRD are conserved. Since protein phosphorylation may disrupt the intramolecular
interaction of a protein, we hypothesized that phosphorylation of one or both of the
intramolecular interaction sites in ALIX relieves the intramolecular interaction of ALIX
and transforms ALIX from closed to open conformation during M phase induction. The
preliminary data from a previous graduate student in our group, Xi Zhou, showed that
ALIX transformed from closed conformation to open conformation in mitotic arrested
HEK293 cells, suggesting that mitotic cells may be a good platform to study the
possible role of phosphorylation in conformational change of ALIX.
To test our hypothesis, I designed and performed this part of study. My study
demonstrates that ALIX phosphorylation at the intramolecular interaction site within the
nPRD relieves the default intramolecular interaction of cytosolic ALIX in mitotic cells
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and that this activating phosphorylation of ALIX is required for ALIX to support
cytokinetic abscission and EIAV budding but does not affect the function of ALIX in
MVB sorting of activated EGFR.

Results
4.1. The intramolecular interaction of cytosolic ALIX is relieved in a
phosphorylation-dependent manner during M phase entry
To determine whether the intramolecular interaction of ALIX is relieved during M
phase

entry,

conformation-sensitive

anti-ALIX

antibodies

were

used

to

immunoprecipitate cytosolic ALIX from asynchronously growing (>95% interphase cells)
or mitotically arrested (>80% mitotic cells) HEK293 cells, which were extracted with the
cell extraction buffer without detergent. The extraction buffer for mitotically arrested
cells contains ATP and the PP1/PP2A inhibitor microcystin to stabilize the M phase
status of the extracts. Immunoprecipitation of asynchronously growing cell lysates (IE)
or mitotically arrested cell lysates (ME) showed that conformation-sensitive anti-ALIX
antibodies, 1A3 and 2H12, specifically immunoprecipitated cytosolic ALIX from ME,
indicating that cytosolic ALIX in ME is in an open conformation. In contrast,
conformation-insensitive anti-ALIX antibodies, 1A12 and 3A9, immunoprecipitated
comparable levels of cytosolic ALIX from both IE and ME (Fig. 22A). Immunoblotting of
IE and ME with the mitotic phosphoprotein monoclonal antibody 2 (MPM-2) (Wu et al.,
2010) showed robust increase of the level of protein phosphorylation in mitotic cells,
demonstrating the mitotic state of ME. Since the extraction buffer for mitotically
arrested cells contains ATP and microcystin, there is a possibility that the added ATP
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and microcystin induce the open conformation of ALIX. To test this possibility, I used
the extraction buffer containing ATP and microcystin to prepare both IE and ME, and
performed immunoprecipitation with the 2H12 and 3A9 antibodies. As shown in Fig.
22B, although the 2H12 antibody immunoprecipitated detectable level of ALIX from IE,
it immunoprecipitated much higher level of ALIX from ME as did the 3A9 antibody,
indicating that the conformational change of ALIX in mitotic cells is not due to the buffer
condition. These results demonstrate that the intramolecular interaction of ALIX is
relieved to transform ALIX from closed conformation to open conformation during M
phase induction.
To further test the conclusion, I examined the interactions between cytosolic
ALIX and some of its partner proteins, such as CHMP4, TSG101, and Src in IE and ME.
These interactions are inhibited by the intramolecular interaction of ALIX. Ectopically
expressing FLAG-CHMP4B or endogenous TSG101 was not co-immunoprecipitated
with cytosolic ALIX in IE. In contrast, both of them were co-immunoprecipitated with
cytosolic ALIX in ME (Fig. 22C-D). These results further support the conclusion.
To determine whether the conformational change of ALIX during M phase entry
is induced by mitotic phosphorylation, I treated ME with calf intestinal alkaline
phosphatase (CIP) and examined the effect on ALIX conformational change. As shown
in Fig. 22E, the 1A3 antibody specifically immunoprecipitated cytosolic ALIX from ME,
indicting the open conformation of ALIX in ME. Treatment of ME with CIP eliminated
the 1A3 immunoprecipitability of ALIX in ME, indicating that mitotic phosphorylation is
required for conformational change of ALIX. To determine whether the phosphorylationinduced open conformation of ALIX is reversible event, purified protein GST-CHMP4B
or in-vitro translated myc-TSG101 was added into ME before CIP treatment, it partially
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rescued the 1A3 immunoprecipitability of ALIX (Fig. 21F-G), suggesting that partner
protein interaction partially keeps the open conformation of ALIX. Immunoblotting of IE,
ME and ME plus CIP with MPM2 demonstrated the mitotic state of ME and the efficacy
of CIP treatment.
These results demonstrate that mitotic phosphorylation induces an open
conformation of ALIX during M phase entry.

90

Figure 22. The intramolecular interaction of cytosolic ALIX is relieved in a
phosphorylation-dependent manner during M phase entry. (A) IE and ME from
HEK293 cells were prepared and immunoblotted with MPM-2 and the 3A9 antibody
(left panel). IE and ME were immunoprecipitated with indicated conformation-sensitive
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or conformation-insensitive anti-ALIX antibodies followed by immunoblotting. (B) IE and
ME from HEK293 cells were prepared with the same extraction buffer containing ATP
and microcystin and immunoblotted with MPM-2 and the 3A9 antibody (left panel). IE
and

ME

were

immunoprecipitated

with

indicated

conformation-sensitive

or

conformation-insensitive anti-ALIX antibodies followed by immunoblotting. (C&D) IE
and ME were immunoprecipitated with indicated antibodies, and immunocomplexes
were immunoblotted to visualize ALIX and FLAG-CHMP4B (C) or ALIX and TSG101
(D). (E) IE, ME and CIP-treated ME were immunoblotted with MPM-2. (F&G) ME was
first incubated with GST or GST-CHMP4B (F) or myc or myc-TSG101 (G) at 4ºC for 2 h,
and then treated with CIP. All the samples were immunoprecipitated with IgG or the
1A3 antibody followed by immunoblotting.
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4.2.

Phosphorylation of ALIXnPRD disrupts the interaction between ALIXBro1 and

ALIXnPRD
Since the intramolecular interaction of ALIX is achieved between Bro1 domain
and nPRD (Fig. 23A), the next step is to determine phosphorylation of which domain is
responsible for relieving the intramolecular interaction. For this purpose, I first treated
in-vitro translated myc-ALIXnPRD with interphase-arrested Xenopus oocyte extracts
(IOE), M phase-arrested Xenopus egg extracts (MEE) or MEE plus CIP and then
incubated the treated myc-ALIXnPRD with immobilized GST-ALIXBro1. Immunoblotting of
input proteins showed that MEE treatment induced a phosphorylation-dependent gel
mobility shift. The results of GST pull-down showed that although IOE or MEE plus CIP
treated myc-ALIXnPRD was pulled down by GST-ALIXBro1, MEE treated myc-ALIXnPRD
could not be pulled down by GST-ALIXBro1 (Fig. 23B), suggesting that phosphorylation
of ALIXnPRD by MEE disrupts the interaction between ALIXnPRD and ALIXBro1. Then, I
treated GST-ALIXBro1 with IOE, MEE, or MEE plus CIP and immobilized treated GSTALIXBro1 onto GSH beads. Immunoblotting of washed GST-ALIXBro1 with anti-p-Tyr
antibody demonstrated that ALIXBro1 was phosphorylated by MEE (Fig. 23C). The
ability of washed GST-ALIXBro1 to interact with myc-ALIXnPRD was examined by GST
pull-down. MEE-treated GST-ALIXBro1 still pulled down myc-ALIXnPRD, although its
ability decreased by ~30% compared to IOE or MEE plus CIP treated GST-ALIXBro1
(Fig. 23D). The results suggest that phosphorylation of ALIXBro1 by MEE only weakens
the interaction between ALIXnPRD and ALIXBro1.
Taken together, these results indicate that phosphorylation of ALIXnPRD plays a
major role in relieving the intramolecular interaction of ALIX.
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Figure 23. Phosphorylation of ALIXnPRD disrupts the interaction between ALIXBro1
and ALIXnPRD. (A) Schematic illustration of ALIX and ALIX fragments used in this study.
(B) The in vitro translated myc-ALIXnPRD was incubated with IOE, MEE, or MEE plus
CIP. GST pull-down was used to examine the interaction between treated mycALIXnPRD and immobilized GST-ALIXBro1. Input of the treated myc-ALIXnPRD was
immunoblotted; the gel mobility shift of treated myc-ALIXnPRD was indicated (left panel);
bound proteins from GST pull-down were immunoblotted (right panel). (C) GST or
GST-ALIXBro1 was first incubated with IOE, MEE, or MEE plus CIP, and immobilized
onto GSH beads. The beads was washed and immunoblotted with an antiphosphotyrosine (p-Tyr) antibody. (D) GST or GST-ALIXBro1 was first incubated with
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IOE, MEE, or MEE plus CIP, and then immunoblized onto GSH beads. The beads were
washed and then incubated with in-vitro translated myc-ALIXnPRD. GST pull-down was
used to examine the interaction between treated myc-ALIXnPRD and myc-ALIXnPRD (left
panel). The level of myc-ALIXnPRD pulled down by treated GST-ALIXBro1 was quantified
and plotted (right panel).
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4.3. Phosphorylation of both S718 and S721 residues disrupts the interaction
between ALIXnPRD and ALIXBro1
Since the studies above demonstrate that phosphorylation of ALIXnPRD makes
major contribution to disrupting the intramolecular interaction, I focused on ALIXnPRD in
the following studies. Sequence alignment of ALIXnPRD and Xp95nPRD showed that two
conserved residues, Ser718 (S718) and Ser721 (S721) in ALIXnPRD, locate at one of
the intramolecular interaction site (residues 717-720: PSAP) (Fig. 24A). Since
phosphorylation may disrupt the protein interaction, I hypothesized that phosphorylation
at the S718 and S721 residues may be responsible for disrupting the interaction
between ALIXBro1 and ALIXnPRD. To test this hypothesis, I first examined whether these
two residues in ALIXnPRD are phosphorylated in our in-vitro experimental system.
For this purpose, phospho-specific antibodies that recognize the phosphorylated
S718 and S721 residues were needed. First, we found that the Phospho-(Ser/Thr) PKD
Substrate Antibody from Cell Signaling Technology (Catalog number: #4381) detects
peptides and proteins containing a phospho-S/T residue with arginine at the -3 position
and leucine at the -5 position, preferring proline at the -1 position. Since the S718
context fits these criteria, the #4381 antibody was used to determine whether the S718
residue in ALIXnPRD is phosphorylated by MEE treatment. We also produced rabbit
polyclonal antibodies against a synthetic ALIX peptide that is phosphorylated at both
S718 and S721 residues. The antibody, which was named as anti-pS2 antibody, was
also used in the following studies.
As shown in Fig. 24B, the #4381 antibody recognized MEE-treated WT GSTALIXnPRD, but not mock-treated WT GST-ALIXnPRD or MEE-treated phosphodefective
S718A-S721A (S2A) mutant form GST-ALIXnPRD. Immunoprecipitation with the #4381
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antibody showed that the #4381 antibody specifically immunoprecipitated MEE-treated
WT myc-ALIXnPRD, but not mock-treated WT myc-ALIXnPRD or MEE-treated S2A mycALIXnPRD. These results suggest that the S718 residue in ALIXnPRD is phosphorylated
by MEE treatment. As shown in Fig. 24C, the anti-pS2 antibody specifically recognized
MEE-treated GST-ALIXnPRD, and also specifically immunoprecipitated MEE-treated
myc-ALIXnPRD. These results further demonstrate that the S718 and S721 residues in
ALIXnPRD are phosphorylated by MEE treatment.
To determine whether phosphorylation at the S718 and S721 residues by MEE
disrupts the interaction between ALIXnPRD and ALIXBro1, I further made constructs of
myc-ALIXnPRD containing phosphomimetic mutations at the S718 and S721 residues
(S718D-S721D, S2D) or phosphodefective mutations at the adjacent residues S712
and S729 (S712A-S729A, S2A-). The S2A, S2D or S2A- myc-ALIXnPRD was treated
with IOE, MEE or MEE plus CIP and pulled down by GST-ALIXBro1. As shown in Fig.
24D, GST-ALIXBro1 pulled down S2A myc-ALIXnPRD under all three conditions, pulled
down S2A- myc-ALIXnPRD only upon treatment with IOE or MEE plus CIP but did not
pull down S2D myc-ALIXnPRD under any of the conditions. These results suggest that
phosphorylation at the S718 and S721 residues are required to disrupt the interaction
between ALIXBro1 and ALIXnPRD.
To further determine whether the disruption of the interaction between ALIXBro1
and ALIXnPRD is a direct effect from phosphorylation or an indirect effect from
phosphorylation-dependent recruitment of cofactors, I examined this interaction by
using GST pull-down in the absence of any treatment. As shown in Fig. 24E, GSTALIXBro1 pulled down comparable levels of WT, S2A or S2A- myc-ALIXnPRD, but an
undetectable level of S2D myc-ALIXnPRD. The results indicate that phosphorylation at
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S718 and S721 residues directly disrupts the interaction between ALIXBro1 and
ALIXnPRD.
The S718 residue localizes in a context that fits the phosphorylation consensus
sequences for PLK1 and PKD. To determine whether PLK1 and PKD, both of which
are active in mitosis (Golsteyn et al., 1995; Kienzle et al., 2013), are responsible for
phosphorylating the S718 and S721 residues, I pre-treated MEE with DMSO, PKD
inhibitor CID755673, PLK1 inhibitor BI-2536, combination of both inhibitors, and pankinase inhibitor staurosporine. Then, the treated MEE was used to phosphorylate GSTALIXnPRD in the presence of these inhibitors. Immunoblotting with the anti-pS2 antibody
showed that the pan kinase inhibitor significantly inhibited the phosphorylation of GSTALIXnPRD. However, the PKD and PLK1 inhibitors only reduced the phosphorylation of
GST-ALIXnPRD by ~17% and ~35%, respectively, and together reduced the
phosphorylation by ~41% (Fig. 24F). These results suggest that PLK1 and PKD are
among the multiple kinases in MEE that phosphorylate the S718 and S721 residues in
ALIXnPRD.
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Figure 24. Phosphorylation of both S718 and S721 residues disrupts the
interaction between ALIXnPRD and ALIXBro1. (A) Sequence alignment of ALIXnPRD
and Xp95nPRD; conserved S/T residues are highlighted. (B) WT and S2A GST-ALIXnPRD
were mock treated or incubated with MEE and immobilized onto GSH beads. The
beads were washed and immunoblotted with the #4381 antibody (left panel). In-vitro
translated myc-ALIXnPRD was mock-treated or incubated with MEE. The treated mycALIXnPRD was immunoprecipitated under denaturing condition (dIP) with the #4381
antibody followed by immunoblotting (right panel). (C) WT and S2A GST-ALIXnPRD were
mock treated or incubated with MEE and immobilized onto GSH beads. The beads
were washed and immunoblotted with the anti-pS2 antibody (left panle). In-vitro
translated myc-ALIXnPRD was mock-treated or incubated with MEE. The treated mycALIXnPRD was immunoprecipitated under denaturing condition (dIP) with the anti-pS2
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antibody followed by immunoblotting (right panel). (D) In vitro translated products of
indicated forms of myc-ALIXnPRD were incubated with IOE, MEE, or MEE plus CIP, and
immunoblotted with anti-myc antibodies (left panel). The interaction between treated
myc-ALIXnPRD and GST-ALIXBro1 was examined by GST pull-down (right panel). (E) In
vitro translated products of indicated forms of myc-ALIXnPRD were incubated with
immobilized GST or GST-ALIXBro1. Input and pull-down proteins were immunoblotted.
(F) GST-ALIXnPRD was mock treated or incubated with MEE in the presence or absence
of PKD inhibitor CID755673 (CID), PLK1 inhibitor BI-2536 (BI), both inhibitors (C+B) or
pan-kinase inhibitor staurosporine (ST). Then, the treated GST-ALIXnPRD was
immobilized onto GSH beads, which was washed after binding, and immunoblotted
with the anti-pS2 antibody (left panel). Relative levels of phosphorylated GST-ALIXnPRD
were determined and normalized against the level of total GST-ALIXnPRD (right panel).
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4.4.

Phosphorylation of both S718 and S721 residues transforms ALIX from

close conformation to open conformation in mitotic cells
To determine whether the S718 and S721 residues are also phosphorylated in
mitotic cells, I first performed denaturing immunoprecipitation (dIP) of IE and ME by
using the #4381 antibody. The results showed that the #4381 antibody specifically
immunoprecipitated ALIX from ME, indicating that the S718 residue is phosphorylated
in mitotic cells. Then, I performed dIP of IE and ME by using the 3A9 antibody followed
by immunoblotting of immunocomplex with the anti-pS2 antibody. The results showed
that the anti-pS2 antibody specifically recognized ALIX in ME, indicating that both S718
and S721 residues are phosphorylated in mitotic cells (Fig. 25A).
To determine whether the recognition by two phospho-specific antibodies is due
to the phosphorylation at the S718 and S721 residues, I transfected HEK293 cells with
WT or S2A GFP-ALIX and performed dIP of IE and ME by using the #4381 antibody.
The results showed that the #4381 antibody specifically immunoprecipitated WT GFPALIX from ME, but not IE. The #4381 antibody did not immunoprecipitate S2A GFPALIX from either IE or ME. The dIP of IE and ME was also performed by using antiGFP antibody followed by immunoblotting of immunocomplex with the anti-pS2
antibody. The results showed that the anti-pS2 antibody specifically recognized WT
GFP-ALIX from ME, but not IE. Similar to the #4381 antibody, the anti-pS2 antibody
also did not recognize S2A GFP-ALIX from either IE or ME (Fig. 25B-C). The results
further demonstrate that the S718 and S721 residues are phosphorylated in mitotic
cells.
To determine whether phosphorylation at the S718 and S721 residues are
responsible for relieving the intramolecular interaction of ALIX in mitotic cells, I
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transfected HEK293 cells with WT, S2A, S2D or S2A- GFP-ALIX and performed
immunoprecipitation of IE and ME with the 2H12 and 3A9 antibodies. As shown in Fig.
25D, the 2H12 antibody only immunoprecipitated S2D GFP-ALIX from IE, indicating
that only S2D GFP-ALIX is in the open conformation in IE. The 2H12 antibody
immunoprecipitated WT, S2D and S2A- GFP-ALIX from ME. In contrast, the 2H12
antibody did not immunoprecipitate S2A GFP-ALIX from either IE or ME, indicating that
S2A GFP-ALIX could not transform to the open conformation in mitotic cells. The 2H12immnuprecipitable GFP-ALIX was also co-immunoprecipitated with CHMP4B and
TSG101. These results demonstrate that phosphorylation at the S718 and S721
residues are responsible for relieving the intramolecular interaction of ALIX and
inducing the open conformation of ALIX in mitotic cells.
To determine whether phosphorylation at both residues are required for relieving
the intramolecular interaction of ALIX, I transfected HEK293 cells with WT, S718A,
S721A or S2A GFP-ALIX and performed immunoprecipitation of ME with the 2H12 and
3A9 antibodies. As shown in Fig. 25E, the levels of S718A GFP-ALIX and S721A GFPALIX immunoprecipitated by the 2H12 antibody are ~40% and ~70% of the level of WT
GFP-ALIX immunoprecipitated by the 2H12 antibody. These results suggest that
complete relieve of the intramolecular interaction of ALIX requires phosphorylation at
both S718 and S721 residues. Co-IP results showed that mutations at S718 and S721
residues did not affect ALIX interaction with TSG101 (Fig. 25F).
To

determine

whether

PLK1

or/and

PKD

are

also

responsible

for

phosphorylating the S718 and S721 residues in mitotic cells, HEK293 cells were
synchronized in mitosis in the presence or absence of the PLK1 inhibitor and/or the
PKD inhibitor, or the pan kinase inhibitor, and determined the phosphorylation of ALIX
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with the anti-pS2 antibody. As shown in Fig. 25G-H, the immunoblotting of the whole
cell lysates with MPM-2 showed that only the pan kinase inhibitor inhibited mitotic entry.
The PKD inhibitor inhibited the phosphorylation of the S718 and S721 residues in ALIX
by ~15%, the PLK1 inhibitor inhibited the phosphorylation by ~25% and the
combination of two inhibitors inhibited the phosphorylation by ~39%. As anticipated, the
pan kinase inhibitor completely inhibited the phosphorylation. These results suggest
that PKD and PLK1 are among the multiple protein kinases that phosphorylate the
S718 and S721 residues in ALIX in mitotic cells.
Taken together, these results demonstrate that the phosphorylation at the 718
and S721 residues in mitotic cells completely relieves the intramolecular interaction of
ALIX.
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Figure 25. Phosphorylation of both S718 and S721 residues transforms ALIX
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from close conformation to open conformation in mitotic cells. (A) IE and ME from
HEK293 cells were immunoblotted with MPM2 (left panel). IE and ME were
immunoprecipitated under denaturing condition (dIP) with the #4381 antibody followed
by immunoblotting (middle panel). IE and ME were immunoprecipitated under
denaturing condition (dIP) with the 3A9 antibody followed by immunoblotting with the
3A9 antibody and anti-pS2 antibody (right panel). (B&C) HEK 293 cells were
transfected with WT or S2A GFP-ALIX. IE and ME from these transfected cells were
immunoprecipitated under denaturing condition (dIP) with the #4381 antibody followed
by immunoblotting with an anti-GFP antibody (B), or with an anti-GFP antibody followed
by immunoblotting with an anti-GFP antibody and the anti-pS2 antibody (C). (D)
HEK293 cells were transfected with WT or indicated mutant forms of GFP-ALIX. IE
and ME these transfected cells were immunoblotted with indicated antibodies or
immunoprecipitated with indicated anti-ALIX antibodies followed by immunoblotting. (E)
HEK293 cells were transfected with WT or indicated mutant forms of GFP-ALIX. IE and
ME from these transfected cells were immunoprecipitated with indicated anti-ALIX
antibodies. Input proteins and immunocomplexes were immunoblotted with an antiGFP antibody. (F) HEK293 cells were co-transfected FLAG-TSG101 and GFP, WT,
S2A, or S2D GFP-ALIX. IE from these transfected cells were immunoprecipitated with
anti-FLAG antibodies in the presence of 1% Triton X-100. Input proteins and
immunocomplexes were immunoblotted. (G&H) HEK293 cells were cultured in the
presence of 2.5 mM TdR for 16 h. The cells were either cultured in the continued
presence of TdR or in the presence of 100 ng/ml nocodazole (NC). At 5-6 h after NC
block, when most of cells had not entered mitosis, DMSO, CID (3 µM), BI (100 nM),
both inhibitors (CID+BI: 3 µM+100 nM) or ST (50 nM) were added to the culture
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medium, and cells were further cultured for 2-3 h to be accumulated in mitosis. IE and
ME from collected cells were immunoblotted with MPM2 (G) or immunoprecipitated
under denaturing condition with the 3A9 antibody followed by immunoblotting with the
3A9 antibody and anti-pS2 antibody. Relative levels of the phosphorylated ALIX were
determined and normalized against the levels of total ALIX (H).
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4.5.

The activating phosphorylation of ALIX is required for ALIX to recruit

CHMP4 to the midbody
ALIX has been demonstrated to be critically involved in ESCRT-mediated
cytokinetic abscission. During cytokinetic abscission, ALIX and TSG101 were recruited
to the midbody through direct interaction with Cep55. ALIX and TSG101 promoted
ESCRT-III assembly at the midbody through recruiting CHMP4 (Carlton et al., 2008).
Since the intramolecular interaction of ALIX prohibits ALIX interaction with CHMP4, I
hypothesized that phosphorylation at the S718 and S721 residues that relieves the
intramolecular interaction of ALIX is required for ALIX to support cytokinetic abscission.
To test this hypothesis, I first determined whether ALIX is required for CHMP4 or
TSG101 recruitment to the midbody. For this purpose, the ALIX knockdown HeLa cells
were transfected with mCherry-CHMP4B or mCherry-TSG101, fixed and stained with
anti-tubulin antibody. As shown in Fig. 26A, knockdown of ALIX inhibited the midbody
localization of mCherry-CHMP4B in ~70% of the midbody-stage cells examined. In
contrast, knockdown of ALIX did not affect the midbody localization of mCherryTSG101 (Fig. 26B). These results suggest that ALIX is important for the midbody
localization of CHMP4.
To further determine the role of the activating phosphorylation of ALIX in
recruiting CHMP4 to the midbody, I ectopically expressed WT, S2A, or S2A- GFPALIX* in the ALIX knockdown HeLa cells and examined the effects on the midbody
localization of mCherry-CHMP4B. As shown in Fig. 26C, although WT or S2A- GFPALIX* rescued the midbody localization of mCherry-CHMP4B to the near control level,
S2A GFP-ALIX* did not have the rescuing effects. These results suggest that the

107

phosphorylation at the S718 and S721 residues are required for ALIX to recruit CHMP4
to the midbody.
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Figure 26. The activating phosphorylation of ALIX is required for ALIX to recruit
CHMP4 to the midbody. (A&B) HeLa cells were transfected with mCherry-CHMP4B
(A) or mCherry-TSG101 (B), fixed and stained with anti-tubulin antibody (green). Cell
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lysates were immunoblotted to visualize ALIX, mCherry-CHMP4b (A), mCherryTSG101 (B) and actin (left panel). The average percentages of mCherry positive cells
with midbody localization of mCherry-CHMP4b and SDs (A) or mCherry-TSG101 (B)
were determined from three independent experiments and plotted (left panel).
Representative images are shown with the squares showing the 5× enlarged midbody
areas. Solid and hollow arrowheads indicate the presence and absence of mCherryCHMP4b (A) or mCherry-TSG101 (B) at the midbody, respectively. Scale bar: 50 µm.
(C) HeLa cells were transfected with indicated siRNAs for 72 h, and cell lysates were
immunoblotted with indicated antibodies to visualize ALIX and actin. Fixed cells were
immunostained with an anti-tubulin antibody (red), and counterstained with DAPI (blue).
The average percentages of midbody-stage cells or multinucleated cells and SDs were
determined from three independent experiments and plotted. Representative images
are shown with solid and hollow arrows indicating mononucleated and multinucleated
cells, respectively, and hollow arrowheads indicating midbodies between daughter cells.
Scale bar: 50 µm.
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4.6.

The activating phosphorylation of ALIX is required for ALIX to support

cytokinetic abscission
The midbody localization of CHMP4 is essential for cytokinetic abscission. Thus,
I then determined whether the activating phosphorylation of ALIX is required for
cytokinetic abscission. As shown in Fig. 27, knockdown of ALIX in HeLa cells increased
the percentages of midbody-stage and multinucleated cells from <2% to ~14% and
~17%, respectively. Ectopic expressing WT, S2A or S2A- GFP-ALIX* localized at the
midbody in the ALIX knockdown cells. Although WT or S2A- GFP-ALIX* rescued the
percentages of midbody-stage and multinucleated cells to the near control levels, S2A
GFP-ALIX* did not have the rescuing effects. These results demonstrate that the
phosphorylation at the S718 and S721 residues are important for ALIX to support
cytokinetic abscission.
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Figure 27. The activating phosphorylation of ALIX is required for ALIX to support
cytokinetic abscission. HeLa cells were transfected with indicated siRNAs for 48 h
and then transfected with indicated constructs for 24 h before fixation. The fixed cells
were stained with an anti-tubulin antibody (red). Cell lysates were immunoblotted to
visualize GFP-ALIX, ALIX and actin (left panel). The percentages of GFP-positive
midbody-stage cells and multinucleated cells were scored and plotted (left panel).
Representative images are shown with solid and hollow arrows indicating GFP-positive
mononucleated and multinucleated/midbody-stage cells, respectively. Scale bar: 50 µM.
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4.7. The activating phosphorylation of ALIX is required for ALIX to support EIAV
budding
ALIX has been demonstrated to be critically involved in ESCRT-mediated EIAV
budding, which is a model system for studying of retroviral budding. ALIX involvement
in EIAV budding requires ALIX interaction with p9GAG and CHMP4 (Strack et al., 2003).
Thus, I hypothesized that the activating phosphorylation of ALIX is important for it to
support EIAV budding.
To test this hypothesis, I first confirmed the previous reports that ALIX
interaction with p9GAG needs opened ALIX by showing that GST-p9GAG specifically
pulled down ALIX from ME, but not IE (Fig. 28A). Moreover, p9GAG interaction with
opened ALIX could partially keep the open conformation of ALIX even after
dephosphorylation of ALIX (Fig. 28B).
To determine whether there is a conformational change of ALIX during EIAV
budding, HEK293 cells were co-transfected with an infection-defective EIAV Gag
(pEV53B-GagEIAV) and WT, S2A or S2A- GFP-ALIX, and the conformation of GFPALIX was examined by immunoprecipitation with the 1A3 antibody. As shown in Fig.
28C, expression of GagEIAV induced 1A3-immunoprecipitable WT or S2A- GFP-ALIX,
suggesting that the activating phosphorylation is required for generating opened ALIX
during EIAV budding.
To determine whether the activating phosphorylation of ALIX is required for it to
support EIAV budding, the ALIX knockdown HEK293 cells were co-transfected with
pEV53B-GagEIAV and WT, S2A, or S2A- GFP-ALIX*, and the levels of VLPs were
examined by collecting the VLPs through ultracentrifugation of culture medium followed
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by immunoblotting with anti-CA antibody. As shown in Fig. 28D, knockdown of ALIX
significantly inhibited the budding VLPs, consistent with the previous studies (Strack et
al., 2003; von Schwedler et al., 2003). Ectopic expression of WT or S2A- GFP-ALIX*,
but not S2A GFP-ALIX, rescued the defect in EIAV budding, suggesting that the
phosphorylation at S718 and S721 residues are important for ALIX to support EIAV
budding. Further studies showed that arresting cells in mitosis blocked EIAV budding
and that arresting cells in interphase did not affect EIAV budding (Fig. 28E), suggesting
that EIAV budding only happens in interphase.
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Figure 28. The activating phosphorylation of ALIX is required for ALIX to support
EIAV budding. (A) GST or GST-p9 was incubated with IE or ME from HEK293 cells.
Input and bound proteins were immunoblotted to visualize ALIX, GST and GST-p9. (B)
ME from HEK293 cells was incubated with GST or GST-p9 at 4ºC for 2 h, and then
treated with CIP. The samples were immunoprecipitated with IgG or the 1A3 antibody,
followed by immunoblotting to visualize ALIX, GST and GST-p9. (C) HEK293 cells
were co-transfected with pEV53B EIAVGag and indicated forms of GFP-ALIX. IE from
the transfected cells were immunoprecipitated with indicated anti-ALIX antibodies. Input
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and immunocomplexes were immunoblotted to visualize GFP-ALIX, Gag and actin. (DF) HEK293 cells were processed as diagrammed. VLPs and cell lysates were
immunoblotted with indicated antibodies. Relative levels of VLPs production and SDs
were determined from three independent experiments and plotted.
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4.8.

The activating phosphorylation of ALIX is not important for ALIX to support

MVB sorting of activated EGFR
ALIX has been demonstrated to be critically involved in ESCRT-III mediated
MVB sorting of activated EGFR. Calcium-dependent ALG-2 interaction with ALIX
activates the MVB sorting function of ALIX through relieving its intramolecular
interaction.

To determine whether the activating phosphorylation collaborates with

ALG-2 interaction to promote MVB sorting of activated EGFR, I first examined whether
the activating phosphorylation is required for EGF-stimulated increase of ALIX
association with the membrane by using membrane flotation centrifugation. As shown
in Fig. 29A, EGF stimulation increased the percentage of membrane associated WT or
S2A GFP-ALIX from ~10% to ~30%. In contrast, the membrane association of ∆PxY
GFP-ALIX is dramatically decreased irrespective of EGF stimulation. These results
suggest that the activating phosphorylation is not important for EGF-stimulated ALIX
association with the membrane.
I then determined whether the activating phosphorylation is required for ALIX to
promote MVB sorting of activated EGFR by using proteinase K protection assay. As
shown in Fig. 29B, after 30 min of EGF stimulation, the percentage of protected EGFR
is ~60%, indicating that ~60% of EGFR was sorted into the lumen of MVB. Knockdown
of ALIX decreased the percentage of protected EGFR from ~60% to ~15%. WT, S2A or
S2A- GFP-ALIX similarly rescued the protected percentage of EGFR to the near control
level, suggesting that the activating phosphorylation is not important for ALIX to support
MVB sorting of activated EGFR. Further, I determined the effects of the activating
phosphorylation on the downstream signaling of activated EGFR by examining the
levels of EGF-stimulated p-ERK1/2. As shown in Fig. 29C-D, knockdown of ALIX
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prolonged the duration of p-ERK1/2 from 10 min to 60 min. WT or S2A GFP-ALIX*
rescued the effect of ALIX knockdown, reducing the duration of p-ERK1/2 to 10 min.
These results support our conclusion.
Finally, I determined the effects of the activating phosphorylation on EGFinduced EGFR degradation under EGF continuous stimulation condition. As shown in
Fig. 29E-F, knockdown of ALIX retarded the 50% EGFR degradation from 1 h to 2 h.
Although ∆PxY GFP-ALIX* did not rescue the retardation effect of ALIX knockdown on
EGFR degradation, WT or S2A GFP-ALIX* could rescue the retardation effect,
indicating that the activation phosphorylation of ALIX is not important for ALIX to
function in the degradation of activated EGFR.
Taken together, these results demonstrate that the phosphorylation at S718 and
S721 residues is not important for ALIX to support MVB sorting of activated EGFR.
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Figure 29. The activating phosphorylation of ALIX is not important for ALIX to
support MVB sorting of activated EGFR. (A) HEK293 cells were transfected with
indicated forms of GFP-ALIX and stimulated with or without EGF for 1 h. PNSs were
fractionated by membrane flotation centrifugation. M and S fractions was determined by
immunoblotting with an anti-GFP antibody. The average percentage of each GFP-ALIX
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in the M fraction and SDs was determined and plotted. (B-F) HEK293 cells were
transfected and serum-starved as diagrammed. (B) These cells were stimulated with
EGF for 30 min before being assayed by the proteinase K protection assay. The
average percentages of proteinase K-insensitive EGFR were determined and plotted.
Error bars indicate the range of the data. (C&D) Cells were stimulated with EGF for
indicated minutes, and cell lysates were immunoblotted to visualize p-ERK, ERK, GFPALIX and ALIX. The relative levels of p-ERK at different time points were determined
and normalized against the level of si-NC cells at 60 min. (E&F) Cells were stimulated
with EGF for indicated hours, and cell lysates were immunoblotted to visualize EGFR,
GFP-ALIX, ALIX and actin. The percentages of remaining EGFR at different time points
were determined and plotted.
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Discussion
My results show that ALG-2 is not important for ALIX-mediated cytokinetic
abscission or retroviral budding, suggesting that different mechanisms are required to
activate ALIX in these two processes. Using mitotic cells as the platform, I discovered
that phosphorylation of the S718 and S721 residues at or near the intramolecular
interaction site within the nPRD of ALIX in mitotic cells relieves the intramolecular
interaction of ALIX and that multiple protein kinases, including PLK1 and PKD, are
responsible for this activating phosphorylation. The functional studies demonstrate that
this activating phosphorylation is required for ALIX to support cytokinetic abscission
and retroviral budding, but is not important for MVB sorting of activated EGFR.
Cytokinetic abscission happens in early interphase when most of the mitotic
kinases have been inactivated. How the mitotic phosphorylation-induced open
conformation of ALIX can be maintained in interphase to support cytokinetic abscission?
There are two possible explanations. One is that multiple mitotic kinase and
phosphoproteins remain active at the midbody after mitotic exist. For example, the
midbody was specifically recognized by the mitotic phosphoprotein monoclonal
antibody MPM-2 (Sun et al., 2016; Vandre et al., 1986), by antibodies that recognize
activated MEK, ERK and RSK (Sun et al., 2016; Willard and Crouch, 2001), by
antibodies that recognize aurora B (Crosio et al., 2002; Sun et al., 2016), and by
antibodies that recognize citron kinase and its activator RhoA (Madaule et al., 1998;
Sun et al., 2016). Thus, it is possible that some of the kinases that catalyze the
activating phosphorylation of ALIX in mitotic cells localize and remain active at the
midbody and continue to catalyze the activating phosphorylation of ALIX. My results
indicate that PLK1 and PKD are among the multiple mitotic kinases that catalyze the
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activating phosphorylation of ALIX. Phosphorylation of Cep55 by PLK1 inhibits
recruitment of Cep55 to the midbody (Bastos and Barr, 2010), making PLK1 less likely
to be the candidate. However, immunostaining with anti-PKD substrate antibodies
showed that the staining is barely detectable in interphase, very high and widespread in
metaphase, decreased and concentrated in the spindle pole and midzone in anaphase
and early telophase, and specifically lingered in the midbody area in late telophase and
the midbody stage after most of the staining disappeared. There also may be
unidentified kinases that remain active in the midbody area. The other explanation is
that opened ALIX recruits CHMP4 and interacts with TSG101 and that the occupation
of these partner proteins keeps the open conformation of ALIX even if ALIX is
dephosphorylated at the midbody. My results indicate that increased occupation by
partner proteins partially maintain the open conformation of ALIX. These two
mechanisms may function together to keep a pool of opened ALIX in the midbody area
to support cytokinetic abscission. The failure of cytokinetic abscission induces
multinucleated cell. Proliferating multinucleated cells are genetically unstable and can
promote tumorigenesis.
Retroviral budding does not expect to happen in mitosis; actually, if the cells are
arrested in mitosis, the retroviral budding is significantly inhibited. Then, how
phosphorylation at the S718 and S721 residues affects retroviral budding? There are
two possible explanations. One possibility is that the infection of retrovirus induces the
activity of certain kinases that catalyze the phosphorylation of ALIX. However, I could
not detect the signal of phosphorylation by using the #4381 antibody or anti-pS2
antibody, suggesting that either the infection does not induce kinase activity or the level
of phosphorylation is too low to be detected by our antibodies. The other possibility is
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that the high level of p9GAG in EIAV expressing cells may occupy the opened ALIX and
keep its open conformation. My results demonstrate that GST-p9GAG interacts with
opened ALIX and partially keeps the open conformation of ALIX even after
dephosphorylation of ALIX. Thus, these two mechanisms may function together to
generate ALIX in open conformation to support retroviral budding.
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Chapter 5: Discussion, perspective and future directions
5.1.

The regulation of ALIX in ESCRT-mediated processes
ALIX is involved in numerous ESCRT-mediated membrane remolding processes,

including MVB sorting, cytokinetic abscission, retroviral budding, plasma membrane
wound repair, exosome biogenesis, autophagy and nuclear envelope reformation, and
all these processes are fundamental cellular processes that are critically involved in cell
growth and survival (Bissig and Gruenberg, 2014; Hurley, 2015). Although much
advancement has been made in discovery of key factors in these multi-step processes,
the regulatory mechanism that links the initiator and the executor of this cascade is still
poorly understood. ALIX is an essential mediator for linking the upstream initiator and
the downstream executor of ESCRT-mediated processes by direct interaction with
cargo proteins and CHMP4. Since CHMP4 interaction is inhibited by the default
intramolecular interaction of ALIX, the regulation of ALIX in ESCRT-mediated
processes is a very important question that should be explored for better understanding
of these essential cellular processes. For investigating the regulation of ALIX in
ESCRT-mediated processes, I chose the three classical ESCRT-mediated processes
as the model systems because these three classical ESCRT-mediated processes are
the most fundamental ones and the mechanisms underlining these processes are well
studied.
Three potential mechanisms that relieve the intramolecular interaction have
been proposed in previous studies from our group (Zhou et al., 2010). One is partner
protein interaction-induced conformational change; another one is competitive bindinginduced disruption of intramolecular interaction; the third one is posttranslational
modification-induced disruption of intramolecular interaction.
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My studies demonstrate that calcium-dependent ALG-2 interaction with ALIX
specifically activates MVB sorting function of ALIX and that phosphorylation at the
S718 and S721 residues in the nPRD specifically activates the function of ALIX to
support cytokinetic abscission and retroviral budding (Fig. 30).
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Figure 30. Graphic abstract illustrating the mechanisms that activate ESCRT
functions of ALIX in three classical ESCRT-mediated processes (Sun et al., 2016).
(Permission obtained from Cell Press, License No.: 3830440570477)
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5.2. The implication of the two regulatory mechanisms in ESCRT-mediated
processes
Since ALG-2 interaction with ALIX is calcium dependent (Missotten MTrioulier et
al., 2004; Shibata et al., 2004), it is possible that the ESCRT-mediated processes that
induce calcium spike will activate ALIX through this mechanism. In my current study,
endocytosis-induced calcium spike promotes ALG-2-mediated activation of ALIX in
MVB sorting of activated EGFR. Plasma membrane damage also induces calcium
spike near the damaged site. ALG-2 is important for recruiting ALIX and ESCRT-III to
the damaged site for repair (Jimenez et al., 2014; Scheffer et al., 2014). Exosome
biogenesis and autophagosome formation share the similar mechanism for MVB
sorting, involving sorting cargo proteins into endosome. Thus, calcium-dependent ALG2 interaction with ALIX may be also involved in activating ALIX in these processes.
Phosphorylation-dependent activation of ALIX happens when the kinases
responsible for catalyzing this phosphorylation are active. Thus, it is possible that
ESCRT-mediated processes that induce the activities of those responsible kinases will
activate ALIX through this mechanism. In my current studies, in mitotic cells, which
have numerous mitotic kinases activated, S718 and S721 residues can be
phosphorylated by some of these kinases. Partner protein occupation maintains the
open conformation of ALIX during cytokinetic abscission, which actually happens in
interphase. Retroviral infection may induce a very low level of phosphorylation at S718
and S721 residues, even falling below our antibody detection range, through either
inducing a very low level of kinase activity or utilizing the basal level of kinase activity.
Low level of phosphorylation may cooperate with partner protein (p6/p9) occupation to
generate a pool of ALIX in open conformation to support retroviral budding. Proper and
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timely nuclear envelope reformation prevents DNA damage and protects genomic
stability (Olmos et al., 2015; Vietri et al., 2015). Recent studies showing that Aurora B
and ULK3 (Unc-51-like kinase 3)-mediated phosphorylation of CHMP4 delayed
cytokinetic abscission through inducing defective ESCRT-III polymerization (Caballe et
al., 2015; Carlton et al., 2012) suggest that phosphorylation-dependent regulation may
be involved in protecting genomic stability and preventing DNA damage. Thus, in the
process of ESCRT-mediated nuclear envelope reformation, which may induce activities
of many kinases, ALIX may be activated in a phosphorylation-dependent manner.
Thus, my studies of regulation of ALIX in the three classical ESCRT-mediated
processes provide perspective into the regulation of all ESCRT-mediated membrane
remolding processes.
5.3.

The implication of ALG-2/ALIX supported MVB sorting in cancer
Based on my studies demonstrating the essential role of ALG-2/ALIX-supported

MVB sorting in silencing of activated EGFR, an interesting question would be: whether
ALG-2/ALIX-supported MVB sorting also regulate other receptor tyrosine kinases or
other types of membrane receptors? Recent studies demonstrated the essential role of
ALIX in MVB sorting of PAR1, a GPCR family member (Dores et al., 2012a). Although
involvement of ALG-2 was not examined in that study, it is reasonable to expect that
ALG-2 is involved in activating ALIX in this process.
In the absence of normal ESCRT function, the signaling of EGFR and other
receptor tyrosine kinases, including Insulin receptor, platelet-derived growth factor
receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR) are
elevated (Engedal and Mills, 2014; Rodahl et al., 2009; Wegner et al., 2011), indicating
that MVB sorting is involved in timely silencing of these receptors. Further studies need
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to use these receptor tyrosine kinases as the model molecules to examine whether
ALG-2 is also involved in MVB sorting of other receptor tyrosine kinases.
Activated receptor tyrosine kinases stimulate cell proliferation and survival, thus
their signaling should be tightly controlled. ALG-2/ALIX-supported MVB sorting is an
important negative regulator of the signaling of these receptors. If MVB sorting pathway
has defects, the signaling of the activated receptors cannot be timely terminated. That
may induce uncontrolled cell proliferation and tumorigenesis (Bache et al., 2004;
Rodahl et al., 2009; Wegner et al., 2011).
My studies provide a novel insight into the over-activation of receptor tyrosine
kinases in cancer cells and suggest that ALG-2/ALIX axis may be a potential target for
cancer therapy.
5.4.

The switch of ALIX between its ESCRT-dependent function and ESCRT-

independent function
Besides the widespread roles of ALIX in ESCRT-mediated processes, ALIX also
performs diverse ESCRT-independent cellular processes. ALIX was shown to regulate
cell adhesion, cell morphology and migration (Pan et al., 2008; Pan et al., 2006;
Schmidt et al., 2003). These studies indicate that cytosolic ALIX is able to perform
these functions. My studies demonstrate that cytosolic ALIX is in closed conformation
and that ALIX in open conformation will associate with membrane. Thus, the possible
scenario is that ESCRT-dependent functions of ALIX require open conformation of
ALIX, while ESCRT-independent functions of ALIX need closed conformation of ALIX.
Then, how ALIX is switched between these two types of functions and its implication in
cancer is an important and interesting question.
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The evidence from the studies in our group indicates that the ESCRTindependent functions of ALIX may promote tumor cell migration. However, if ALIX is
induced to open conformation, opened ALIX may exert malignancy inhibitory effects
through promoting MVB sorting and silencing of activated receptor tyrosine kinases. In
this context, ALG-2 may be an essential factor to regulate the switch of ALIX between
pro-malignant function and anti-malignant function.
5.5.

A potential new strategy to target activated receptor tyrosine kinases
Current therapeutic strategies to target receptor tyrosine kinases in cancer cells

are either targeting a specific type of receptors by using antibody, inhibiting the activity
of a specific type of receptors by small-molecule inhibitors or inhibiting the downstream
signaling of activated receptors by small-molecule inhibitors. The limitation of these
strategies is that we can only target specific type of receptor tyrosine kinases. Then,
other receptor tyrosine kinases may play redundant roles to induce drug-resistance.
If we can develop a compound that can mimic ALG-2/ALIX interaction to induce
open conformation of ALIX, this compound will promote ALIX-supported MVB sorting
and silencing of activated receptor tyrosine kinases. The advantage of this strategy is
that it can target multiple receptor tyrosine kinases simultaneously.
5.6.

Future directions
Our current studies also raise multiple new problems that deserve further

investigations.
1. To examine whether the regulatory mechanisms identified in the current
studies also apply to other ESCRT-mediated processes.
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Besides the three classical ESCRT-mediated processes studied in the current
research, there are many new identified ESCRT-mediated processes. How these
ESCRT-mediated processes are regulated is an important and interesting question. By
using three classical ESCRT-mediated processes, our current studies identified two
regulatory mechanisms: calcium-dependent ALG-2 interaction and phosphorylation.
Future studies would test whether either of them applies to new identified ESCRTmediated processes. There is possible that some of the ESCRT-mediated processes
use neither of these two mechanisms. In this case, further studies may be performed to
explore the novel mechanisms that activate ALIX.
2. To examine whether ALG-2/ALIX-supported MVB sorting applies to other
receptor tyrosine kinases.
EGFR is the model molecule for study of MVB sorting of ubiquitinated receptor
tyrosine kinases. ALG-2 was identified as apoptosis inducing protein and shown to
have dysregulation in many types of cancer. ALIX was also initially found to have
apoptosis inducing effects. Moreover, ALG-2 and ALIX interaction is required for them
to be involved in inducing apoptosis. However, the underlining mechanism is still not
clear. The potential role of ALG-2/ALIX-supported MVB sorting in silencing of receptor
tyrosine kinases is a possible underline mechanism. Thus, in future studies, we need
to examine the effects of ALIX or ALG-2 knockdown on downstream signaling and
degradation of insulin receptor, PDGFR and VEGFR. If positive results are obtained,
further studies may be performed to examine the role of ALG-2/ALIX-supported MVB
sorting in cell proliferation, apoptosis and migration.
3. To identify the kinases responsible for catalyzing the phosphorylation at
S718 and S721 residues of ALIX.
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Based on our current studies showing that even combination of PLK1 and PKD
inhibitors cannot completely inhibit S718-S721 phosphorylation, there are two
possibilities: one is that PLK1 and PKD are among the multiple kinases that play
redundant roles in phosphorylating S718-S721 residues; the other possibility is that the
major kinase(s) that is/are responsible for this activating phosphorylation is still
unidentified. To test these possibilities, we can use GST-ALIXnPRD to pull down proteins
from MEE or ME and wash off the binding proteins. These proteins will be analyzed by
mass spectrometry, which may identify all kinases binding to ALIXnPRD. Then, the
kinase inhibitors will be used to further test the involvement of these kinases.
Identifying the responsible kinases will lead to a better understanding for the
phosphorylation-dependent regulation of ESCRT-mediated processes.
4. To examine the mechanisms that switch ALIX between non-ESCRT
function and ESCRT function.
Our current studies as well as the studies from previous graduate student in our
group indicated that ESCRT function of ALIX may be involved in malignancy inhibition
while non-ESCRT function of ALIX may be involved in promoting cell migration. Thus,
investigating the potential mechanisms that switch ALIX between ESCRT function and
non-ESCRT function will lead to a better understanding for the role of ALIX in cancer
biology. We hypothesize that conformational change of ALIX may be the switch. To test
the hypothesis, we will examine the role of ALIX in cell migration. We will also examine
the effects of constitutive opened ALIX on cell proliferation, cell morphology and
apoptosis. Further studies may develop a compound that can induce the open
conformation of ALIX and examine the malignancy inhibitory effects of the compound.
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Chapter 6: Experimental procedures

Cell culture, transfection, EGF stimulation and cell synchronization
HEK293 and HeLa cells were maintained in Dulbecco’s Modification of Eagle’s
Medium (DMEM) (Mediatech Inc) supplemented with 2 mM L-glutamine and 10% fetal
bovine serum (Atlanta Biologicals). Subconfluent cultures of cells in 60-mm or 35-mm
culture dishes were transfected with siRNAs or expression vectors using GenMute™
siRNA Transfection Reagent or PolyJet™ DNA In Vitro Transfection Reagent
(SignaGen Laboratories) according to manufacturer’s instructions. Transfected cells
were cultured for additional 24 to 48 h before experimental analyses. Transfection with
ALIX-specific siRNAs was done twice (at 0 and 24 h) as performed in multiple previous
studies, due to high abundance of ALIX. siRNAs used in this study are summarized in
Table 2. Mammalian expression vectors used in this study are summarized in Table 3,
and PCR primers used for site-directed mutagenesis and making vectors are
summarized in Table 4.
The calcium ionophore A23187 (Sigma) was solubilized in 0.1% DMSO, and
was added to the culture medium at a final concentration of 10 µM 15 min before cell
collection. Cell permeable calcium chelator BAPTA-AM (Toronto Research Chemicals)
was solubilized in DMSO and added to the culture medium at a final concentration of
10 µM 1 h before EGF stimulation.
Subconfluent cells in 35-mm dishes were switched to serum free DMEM medium
and cultured for ~12 h for serum starvation. For continuous EGF stimulation,
recombinant EGF (Sigma) was added to the serum free DMEM medium at a final
concentration of 100 ng/ml, and cells were cultured further for indicated lengths of time.
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For pulse-chase EGF stimulation, recombinant EGF was added to the serum free
DMEM medium at a final concentration of 100 ng/ml. Serum-starved cells were first
incubated with EGF at 4ºC for 30 min (pulse), and then changed to EGF- and serumfree medium and cultured at 37ºC for indicated lengths of time (chase). The lysosome
inhibitor chloroquine (CQ) (Sigma) was added to the medium at a final concentration of
25 mM, whenever indicated.
To synchronize cells in mitosis, HEK293 cells were first cultured in DMEM
containing 2.5 mM thymidine (Sigma) for 16 h and cultured in fresh DMEM for 3 h to
release the cells. Then, 100 ng/mL nocodazole (NC) (Sigma) was added to DMEM for
mitotic block. To prevent cells into mitosis, HEK293 cells were cultured in DMEM
containing 2.5 mM thymidine (Sigma) for 16-24 hr to be arrested in S phase.
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Table 2. Sequences of siRNAs used in this study
Target
ALIX

Name
si-ALIX(1)

Sequence
5’-GAGAAGAAAUUGCAAGGUUdTdT-3’

ALIX

si-ALIX(2)

5’-GAAGGAUGCUUUCGAUAAAdTdT-3’

ALG-2

si-ALG-2(1)

5’-GGUCGAUCAUAUCCAUGUUdTdT-3’

ALG-2

si-ALG-2(2)

5’-GACAGGAGUGGAGUGAUAUdTdT-3’

Firefly
GL3
luciferase
CHMP4B

si-NC

5’-CUUACGCUGAGUACUUCGAdTdT-3’

si-CHMP4B

5’-AGAAGAGUUUGACGAGGAUdTdT-3’

CHMP4B

si-CHMP4B

5’-CGGAAGAGAUGUUAACGAAdTdT-3’
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Source
SigmaGenosys
SigmaGenosys
SigmaGenosys
SigmaGenosys
SigmaGenosys
SigmaGenosys
SigmaGenosys

Table 3. Mammalian expression vectors used in this study
Vector

Source

pEGFP-C3-based expression vector for GFP-ALIX

A gift from Dr. Masatoshi
Maki (Nagoya, Japan)
(Shibata et al., 2004)

pEGFP-C3-based expression vector for ALIX-siRNA(1)insensitive GFP-ALIX

Made in this study

pEGFP-C3-based expression vector for I212D GFPALIX

Made in this study

pEGFP-C3-based expression vector for ALIX-siRNA(1)insensitive I212D GFP-ALIX

Made in this study

pEGFP-C3-based mammalian expression vector for
ΔPxY GFP-ALIX

A gift from Dr. Masatoshi
Maki (Nagoya, Japan)
(Shibata et al., 2004)

pEGFP-C3-based expression vector for ALIX-siRNA(1)insensitive DM GFP-ALIX

Made in this study

pEGFP-C3-based mammalian expression vector for
S718A GFP-ALIX

Made in this study

pEGFP-C3-based mammalian expression vector for
S721A GFP-ALIX

Made in this study

pEGFP-C3-based mammalian expression vector for
S718A-S721A GFP-ALIX

Made in this study

pEGFP-C3-based mammalian expression vector for
S712A-S729A GFP-ALIX

Made in this study

pEGFP-C3-based mammalian expression vector for
S718A-S721A ALIX-siRNA-insensitive GFP-ALIX (S2A
GFP-ALIX*)

Made in this study

pEGFP-C3-based mammalian expression vector for
S712A-S729A ALIX-siRNA-insensitive GFP-ALIX (S2AGFP-ALIX*)

Made in this study

pEGFP-C3-based mammalian expression vector for
S718D-S721D GFP-ALIX

Made in this study
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pCMV-based expression vector for FLAG-CHMP4b

A gift from Dr. Masatoshi
Maki (Nagoya, Japan)
(Katoh et al., 2003)

pCMV-Tag2C-based mammalian expression vector for
FLAG-ALG-2

A gift from Dr. Changmin
Chen (Boston, MA) (Chen
and Sytkowski, 2005)

pCMV-Tag2C-based mammalian expression vector for
siRNA(1)-insensitive FLAG-ALG-2 (FLAG-ALG-2*)

Made in this study

pCMV-Tag2C-based mammalian expression vector for
E47A FLAG-ALG-2

Made in this study

pCMV-Tag2C-based mammalian expression vector for
E47A/E114A FLAG-ALG-2

Made in this study

pCMV-Tag2C-based mammalian expression vector for
E47A/E114A FLAG-ALG-2*

Made in this study

The pIRES2-based mammalian expression vector for
FLAG–TSG101

A gift from Dr. Wesley I.
Sundquist (Salt Lake City,
UT) (von Schwedler et al.,
2003)

pEGFP-C3-based mammalian expression vector for
GFP-Rab5 (Q79L)

A gift from Jean Gruenberg
(Geneva, Switzerland)
(Brankatschk et al., 2012)

pEV53B-based mammalian expression vector for
infection defective EIAV

A gift from Dr. John Olsen
(Chapel Hill, NC) (Olsen,
1998)

pGEX-4T3 based bacterial expression vector for WT
GST-ALG-2

Made in this study

pGEX-4T3 based bacterial expression vector for
E47A/E114A GST-ALG-2

Made in this study

pGEX-4T3 based bacterial expression vector for
E47A/E114A GST-ALG-2

Made in this study

pGEX-4T3 based bacterial expression vector for GSTp6HIV-Gag

A gift from Dr. Wesley I.
Sundquist (Salt Lake City,
UT) (Fisher et al., 2007)
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pGEX-4T3 based vector bacterial expression for GSTp9EIAV-Gag

A gift from Dr. Wesley I.
Sundquist (Salt Lake City,
UT) (Fisher et al., 2007)

pmCherry-C1-based expression

Made in this study

vector for mCherry-CHMP4b
pmCherry-C1-based expression

Made in this study

vector for mCherry-TSG101
pCS2-MT based TNT expression vector for mycALIXnPRD

Made in this study

pCS2-MT based TNT expression vector for S718AS721A myc-ALIXnPRD

Made in this study

pCS2-MT based TNT expression vector for S712AS729A myc-ALIXnPRD

Made in this study

pCS2-MT based TNT expression vector for S718DS721D myc-ALIXnPRD

Made in this study

pCS2-MT based TNT expression vector for mycTSG101

Made in this study

pCS2-HA based expression vector for HA-Plx1
(Xenopus)

Made in this study

pCS2-HA based expression vector for HA-K82R Plx1
(Xenopus)

Made in this study

pGEX-4T3 based bacterial expression vector GSTALIXnPRD

Made in this study

pGEX-4T3 based bacterial expression vector for GSTALIXBro1

Generated in our previous
studies (Zhou et al., 2009)

pGEX-4T3 based bacterial expression vector for GSTALIX1-746

Generated in our previous
studies (Zhou et al., 2009)

pGEX-4T3 based bacterial expression vector for GSTCHMP4b

Made in this study
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Table 4. PCR primers used in this study
Product

Primers (Forward/Reverse)

ALIX-siRNA(1)
insensitive
GFP-ALIX

5’GAAGAAATTTGGAGAGGAAATTGCAAGGTTAC3’

ΔPxY GFPALIX*

5’GAAGAAATTTGGAGAGGAAATTGCAAGGTTAC3’

5’GTAACCTTGCAATTTCCTCTCCAAATTTCTTC3’

5’GTAACCTTGCAATTTCCTCTCCAAATTTCTTC3’

S718A GFPALIX

5’CATTGCCAGAGAACCTGCTGCTCCTTCAATTCCTACAC3’

S721A GFPALIX

5’GAACCTAGTGCTCCTGCAATTCCTACACCTGC3’

S718A-S721A
GFP-ALIX

5’CATTGCCAGAGAACCTGCTGCTCCTGCAATTCCTACACCTG
3’

5’GTGTAGGAATTGAAGGAGCAGCAGGTTCTCTGGCAATG3’

5’-GCAGGTGTAGGAATTGCAGGAGCACTAGGTTC3’

5’CAGGTGTAGGAATTGCAGGAGCAGCAGGTTCTCTGGCAAT
G3’
S712A-S729A
GFP-ALIX

WT to S712A:
5’CTTAAAGGACTTGCAACAAGCCATTGCCAGAGAACCTAGTG
3’
5’CACTAGGTTCTCTGGCAATGGCTTGTTGCAAGTCCTTTAAG
3’
S712A to S712A-S729A:
5’CTACACCTGCGTATCAGGCCTCACCAGCAGGAGGAC3’
5’GTCCTCCTGCTGGTGAGGCCTGATACGCAGGTGTAG3’

S718A-S721A
ALIX-siRNAinsensitive
GFP-ALIX

5’CATTGCCAGAGAACCTGCTGCTCCTGCAATTCCTACACCTG
3’

S712A-S729A
ALIX-siRNAinsensitive

5’GAAGAAATTTGGGGAGGAGATCGCGAGATTACAGCATGCA
GCA3’

5’CAGGTGTAGGAATTGCAGGAGCAGCAGGTTCTCTGGCAAT
G3’
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GFP-ALIX

5’CTGCTGCATGCTGTAATCTCGCGATCTCCTCCCCAAATTTC
TTC3’

S718D-S721D
GFP-ALIX

5'GCATTGCCAGAGAACCTGATGCTCCTGATATTCCTACACCT
GCG3'
5'CGCAGGTGTAGGAATATCAGGAGCATCAGGTTCTCTGGCAA
TGC3

Y319F-I212D
FLAG-ALIXBro1

5’GAGATAAAATGAAAGATGCCGACATAGCTAAATTGGCTAAT
CAG3’
5’CCTGATTAGCCAATTTAGCTATGTCGGCATCTTTCATTTTAT
CTC3’

FLAG-ALIXV

5’GAGGAATTCGCGTGTCAGTACAGTCT3’
5’TGTTGCGGCCGCAGTCCTTTAAGAGTTCAT3’

638KMK640 to
638
640

EEA
mutation in
ALIX

643NNE645

to

643YKK645

5’CTCACATCAGGAATTTTCAGAAGCGGCGCAATCTAATAATG
AAG3’
5’GCTTCATTATTAGATTGCGCCGCTTCTGAAAATTCCTGATGT
GAG3’
5’CAGAAGCGGCGCAATCTTATAAGAAAGCTAACTTAAGAGAA
G3’

mutation in
ALIX V
domain

5’CTTCTCTTAAGTTAGCTTTCTTATAAGATTGCGCCGCTTCTG
3’

WT

5’GTGACTGTCAGGTCCATCATATCCATGTTTG3’

FLAG-ALG-2*

5’CAAACATGGATATGATGGACCTGACAGTCAC3’

E47A

5’GAGTGATATCAGACACCGCGCTTCAGCAAGCTCTCTC3’

FLAG-ALG-2

5’GAGAGAGCTTGCTGAAGCGCGGTGTCTGATATCACTC3’

E47A/E114A
FLAG-ALG-2

5’GATGATCGATAAGAACGCGCTGAAGCAGGCCCTCTCAG3’

E47A/E114A
FLAG-ALG-2*

5’GTGACTGTCAGGTCCATCATATCCATGTTTG3’

5’CTGAGAGGGCCTGCTTCAGCGCGTTCTTATCGATCATC3’

5’CAAACATGGATATGATGGACCTGACAGTCAC3’
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WT GST-ALG2
E47A/E114A
GST-ALG-2

5’TAAGAATTCCATGGCCGCCTACTCTTAC3’ (EcoR1)
5’TAACTCGAGTCATACGATACTGAAGACCATG3’ (Xho1)
5’TAAGAATTCCATGGCCGCCTACTCTTAC3’ (EcoR1)
5’TAACTCGAGTCATACGATACTGAAGACCATG3’ (Xho1)

mCherryTSG101

5’TAACTCGAGCT ATGGCGGTGTCGGAGAG3’ (Xho I)

pCS2-MTALIXnPRD

5’TAAGAATTCATTAAAGGACTTGCAACAAAGCATTG3’ (EcoRI)

pCS2-MTS718A-S721A
ALIXnPRD

5’TAAGAATTCATTAAAGGACTTGCAACAAAGCATTG3’ (EcoRI)

pCS2-MTS712A-S729A
ALIXnPRD

5’TAAGAATTCATTAAAGGACTTGCAACAAGCCATTG3’ (EcoRI)

pCS2-MTS718D-S721D
myc-ALIXnPRD

5’TAAGAATTCATTAAAGGACTTGCAACAAAGCATTG3’ (EcoRI)

pCS2-MTTSG101

5’TAAGAATTCAATGGCGGTGTCGGAGAG3’ (EcoRI)

pCS2-HA-Plx1
(Xenopus)

5’AATGGGCCCTCAAGTGGCCGGTAAGAAAC3’ (Apa I)

pCS2-HA-Plx1
K82R
(Xenopus)

5’AATGGGCCCTCAAGTGGCCGGTAAGAAAC3’ (Apa I)

pGEX-4T3ALIXnPRD

5’TAAGAATTCCTTAAAGGACTTGCAACAAAGCATTG3’ (EcoRI)

pGEX-4T3CHMP4b

5’TAAGAATTCCATGTCGGTGTTCGGGAAG3’ (EcoRI)

5’TAAGAATTCTCAGTAGAGGTCACTGAGACCG3’ (EcoRI)

5’TAACTCGAGTGGCGCAGCAGTCCC3’ (Xho I)

5’TAACTCGAGTGGCGCAGCAGTCCC3’ (Xho I)

5’TAACTCGAGTGGCGCAGCAGTCCC3’ (Xho I)

5’TAACTCGAGTGGCGCAGCAGTCCC3’ (Xho I)

5’TAACTCGAGTCAGTAGAGGTCACTGAGACCG3’ (Xho I)

5’GCCTCTAGAGCCGAGGCCTTTACGTGTGC3’ (Xba I)

5’GCCTCTAGAGCCGAGGCCTTTACGTGTGC3’ (Xba I)

5’TAACTCGAGTGGCGCAGCAGTCCC3’ (Xho I)

5’TAACTCGAGTTACATGGATCCAGCCCAG3’ (Xho I)
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Protein extraction, immunoblotting and immunoprecipitation
To prepare crude cell lysates for immunoblotting, cells scraped from culture
plates or dishes were pelleted and extracted with cell lysis buffer consisting of 50 mM
Tris-HCl, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5 mM EDTA, 100 µM sodium
orthovanadate 100 µM sodium fluoride, 100 µM sodium pyrophosphate, 1 mM
Dithiothreitol (DTT) and proteinase inhibitor cocktail (Sigma); 100-200 l of cell lysis
buffer was used to extract cells from one 60-mm dish. Cell lysates were cleared by
centrifugation at 16,000 g for 10 min at 4C.
To prepare membrane solubilized cell lysates for immunoprecipitation, pelleted
cells were extracted by sonication in 50-100 µl of cell lysis buffer that omits 0.1% SDS
and includes 10 mM N-Ethylmaleimide (NEM) (Sigma) whenever indicated. Cell lysates
were cleared by centrifugation at 16,000 g for 10 min at 4C and diluted 10 fold before
immunoprecipitation.
To prepare cytosolic proteins from asynchronously growing cells or mitotically
arrested cells for immunoprecipitation or GST pull-down, pelleted cells were sonicated
with 10 volumes of extraction buffer (EB), consisting of 80mM β-glycerophosphate, 20
mM EGTA, 15 mM MgCl2, 150 mM NaCl, 1 mM DTT, and proteinase inhibitor cocktail
(Sigma) (pH 7.4). For extraction of mitotically arrested cells and occasionally also
asynchronously growing cells whenever indicated, EB was freshly supplemented with 1
mM microcystin (Sigma) and 1 mM ATP (Sigma). Cell lysates were cleared by
centrifugation at 16,000 g for 10 min at 4C. CIP (New England Biolabs) was added to
MEE at a final concentration of 1 unit/mg substrate proteins according to the
manufacture’s instruction.
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To prepare cell lysates for dIP, pelleted cells were re-suspended with 10
volumes of denaturing buffer consisting of 50mM Tris-HCl (pH 7.5), 1% SDS, and 5mM
DTT, and sonicated. After the samples were boiled for 5 min and cleared by
centrifugation at 16,000 g for 5 min, they were diluted 10-fold with an SDS neutralizing
immunoprecipitation buffer consisting of 50 mM Tris-HCl (pH 7.5), 250 mM NaCl, 5 mM
EDTA, 0.5% NP-40, 1 mM DTT (Tansey, 2007), and proteinase inhibitor cocktail
(Sigma).
The immunoprecipitation was performed by incubating indicated antibodies with
the cell lysates by rotating at 4C overnight followed by adding Protein A or Protein G
resin (Genscript) to the cell lysates and incubating by rotating at 4C for 1 h. The
immnucomplex

was

washed

five

times

with

the

same

buffer

used

for

immunoprecipitation.
The protein samples were mixed with SDS sample buffer and boiled for 10 min
before being subject to SDS-PAGE. The protein samples on the SDS-PAGE gel were
then transferred onto nitrocellulose (NC) membrane, which was blocked by 5% non-fat
milk in TBST (TBS (50 mM Tris-HCl, 150mM NaCl, PH7.4) plus 0.02% Tween 20) at
room temperature for 1 h. Then, the NC membrane was incubated with primary
antibodies diluted in 3% BSA in TBST at 4C overnight and HRP (horseradish
peroxidase)-conjugated secondary antibodies diluted in 5% non-fat milk in TBST at
room temperature for 2 h. The signal was detected by ECL (enhanced
chemiluminescence) solution. Antibodies used in this study are summarized in Table 5.
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Table 5. Antibodies used in this study
Recognition

Type

Source

Actin

Mouse monoclonal

Sigma-Aldrich. Cat#: A5441

1A3 anti-ALIX

Mouse monoclonal

Made in our previous studies (Pan
et al., 2006)

1A12 antiALIX

Mouse monoclonal

Made in our previous studies (Pan
et al., 2006)

1F7 anti-ALIX

Mouse monoclonal

Made in our previous studies (Pan
et al., 2006)

2H12 antiALIX

Mouse monoclonal

Made in our previous studies (Pan
et al., 2006)

3A9 anti-ALIX

Mouse monoclonal

Made in our previous studies (Pan
et al., 2006)

ALG-2

Rabbit monoclonal

Epitomics. Cat#: 3846-1

Tubulin

Rabbit monoclonal

Cell Signaling. Cat#: 2125S

CHMP4b

Rabbit polyclonal

Santa Cruz. Cat#: sc-134946

*CHMP4A

Rabbit polyclonal

Santa Cruz. Cat#: sc-67229

*CHMP4B/C

Rabbit polyclonal

Abcam. Cat#: ab76334-100

EIAV capsid
antigen (CA)

Mouse monoclonal

A gift from Dr. Robert Mealey
(Pullman, WA) (McGuire et al.,
1994; Mealey et al., 2009)

EEA1

Rabbit

Epitomics. Cat#: 3704-1

monoclonal
EGFR

Rabbit

Epitomics. Cat#: 1902-1

monoclonal
ERK1

Rabbit polyclonal

Santa Cruz. Cat#:sc-94
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ERK2

Rabbit polyclonal

Santa Cruz. Cat#:sc-154

FLAG

Mouse

Pierce .Cat#: MA1-918781

monoclonal
FLAG

Rabbit

Sigma-Aldrich.Cat#: F7425-.2MG

polyclonal
GFP

Mouse

Santa Cruz. Cat#: sc-9996

monoclonal
GST

Rabbit

Santa Cruz. Cat#: sc-459

polyclonal
HA

Rabbit

Santa Cruz. Cat#: sc-805

polyclonal
HA

Mouse

Pierce. Cat#: 26183

monoclonal
IgG

Mouse

Sigma-Aldrich. Cat#: I5381-10MG

IgG

Rabbit

Sigma-Aldrich. Cat#: I5006-10MG

myc

Rabbit polyclonal

Santa Cruz. Cat#: sc-789

MPM2

Mouse monoclonal

Lab reserve

#4381
antibody

Rabbit polyclonal

Cell Signaling. Cat#: 4381

pS2 antibody

Rabbit polyclonal

Made in this study

p-ERK

Mouse

Santa Cruz

monoclonal

Cat#: sc7383

p-Tyr

Mouse monoclonal

Cell Signaling. Cat#: 9416

ubiquitin

Mouse monoclonal

Santa Cruz. Cat#: sc8017

TSG101

Rabbit monoclonal

Epitomics. Cat#: 5377-1
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Membrane floatation centrifugation
The PNS of HEK293 cell lysates was prepared by re-suspending cell pellets in
100 µl of 10% (w/v) sucrose in TE buffer (TBS plus 1 mM EDTA) supplemented with
proteinase inhibitor cocktail. Cells were lysed by sonication followed by centrifugation at
1800 g for 5 min at 4ºC. 0.1 ml of aliquot from each PNS was mixed with 0.4 ml of 85.5%
(w/v) sucrose in TE buffer to generate a final concentration of 73% (w/v) sucrose. This
73% (w/v) sucrose was placed at the bottom of a 4-ml ultracentrifuge tube, above
which 2.3 ml of 65% (w/v) sucrose and 1.2 ml of 10% (w/v) sucrose in TE buffer were
sequentially overlaid. The step sucrose gradients were ultracentrifuged at 100,000 g for
18 h at 4ºC in a Beckman SW55-Ti rotor. After centrifugation, ten 0.4-ml fractions were
collected by pipetting, and equivalent aliquots were taken from collected fractions for
immunoblotting. In a typical execution of this protocol, fractions 3 and 4 contained
membrane vesicles floating to the boundary of the 10% (w/v) and 65% (w/v) sucrose
layers, whereas fractions 9 and 10 contained soluble proteins unable to float up.
Proteinase K protection assay
Mock treated or EGF stimulated cells were collected and pelleted by
centrifugation at 1,800 g for 5 min. Pelleted cells were re-suspended in 10 volumes of
6.5 µg/mL digitonin (Sigma) in PBS, followed by incubation first at room temperature for
5 min and at 4ºC for 30 min. Samples were then centrifuged at 16,000 g at 4ºC for 5
min, and pellets were re-suspended in 10 volumes of homogenization buffer containing
100 mM K2HPO4/KH2PO4, 5 mM MgCl2 and 250 mM sucrose. Three aliquots with the
same volume were taken equally from each sample, which were treated either with
ddH2O, 4 ng proteinase K/µg sample protein or 4 ng proteinase K/µg sample protein
plus 0.1% Triton X-100 at room temperature for 10 min. Proteinase K digestion was
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stopped by adding SDS-PAGE sample buffer followed by being boiled for 10 min, and
proteins were subject to SDS-PAGE and immunoblotting. Proteinase K should digest
all EGFR in the presence of 0.1% Triton X-100, which solubilizes the membrane
vesicles. Thus, the percentage of proteinase K-resistant EGFR in the absence of 0.1%
Triton X-100 relative to total EGFR in ddH2O-treated sample was taken as the
percentage of EGFR sorted into MVBs.
GST pull-down
GST and GST tagged proteins were produced and purified by the transformation
of BL21 Competent E. coli stains (Thermo Fisher Scientific) with pGEX-4T3 based
vectors for GST or GST tagged proteins. The transformed BL21 Competent E. coli
stains were incubated with 0.1 mM IPTG (Sigma) to stimulate the expression of GST or
GST tagged proteins. The E. coli stains were lysed with PBS containing lysozyme
(Sigma), 1 mM DTT, proteinase inhibitor cocktail (PH 7.4) at 4ºC for 30 min. Then,
Triton X-100 was added with the final concentration of 0.5%. The lysates were
sonicated and cleared by centrifugation at 12,000 rpm at 4ºC for 40 min. The
supernatant was incubated with Glutathione beads (GenScript) at 4ºC overnight. The
beads were washed with buffer I, buffer II and buffer III, sequentially. The GST or GST
tagged proteins were eluted by incubating the beads with elution buffer containing 50
mM Tris-HCl, 150 mM NaCl, 1 mM DTT, proteinase inhibitor cocktail and 50 mM
Glutathione (Sigma) at room temperature for 15 min. The elution step was repeated
twice.
For GST pull-down, the GTS or GST-tagged proteins, either untreated or treated,
were first immobilized onto Glutathione beads by rotating at 4ºC for 2 h. The
immobilized beads were then incubated with either cell lysates or in-vitro translated
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proteins at 4ºC for 2 h. In vitro transcription and linked translation was performed by
using the TNT QuickCoupled Transcription/Translation System (Promega) according to
the manufacturer’s instruction. The beads were washed five times with the same buffer
used during pull-down. The samples were then mixed with SDS-sample buffer and
subject to SDS-PAGE.
Biotinylation of cell surface proteins and affinity absorption of biotinylated
proteins
Serum-starved HEK293 cells cultured in 6-well plates were stimulated with 100
ng/ml EGF for indicated lengths of time followed by rinse with ice-cold PBS (pH 7.4)
supplemented with 1.5 mM MgCl2 and 0.2 mM CaCl2. The cells were then incubated
twice (15 min each time) on a shaker with 200 mg/ml freshly prepared cold sulfo-NHSSS-biotin solution (0.75 ml/well) (bioWORLD) at 4°C, and quenched by wash with
quenching solution (PBS supplemented with 1.5 mM MgCl2, 0.2 mM CaCl2 and 100
mM glycine, pH 7.4) and further incubation in this solution at 4°C for 30 min. Cell
lysates were prepared with cell lysis buffer consisting of 50 mM Tris-HCl, 150 mM NaCl,
1% Triton X-100, 0.5 mM EDTA, 100 µM sodium orthovanadate, 100 µM sodium
fluoride, 100 µM sodium pyrophosphate, 1 mM DTT and proteinase inhibitor cocktail
and incubated with Streptavidin Separopore (Agarose) 4B (bioWORLD) at 4°C
overnight. Pelleted beads were then washed five times with the same buffer used in
incubation and proteins were eluted with SDS sample buffer for immunoblotting.
In Vitro Phosphorylation of ALIX Fragments with Xenopus Extracts
MEE and IOE were prepared in the previous studies in our laboratory (Wu et al.,
2010).
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The in vitro phosphorylation reaction was performed by mixing one volume of
substrate proteins and three volumes of IOE or MEE at room temperature for 2 h
unless otherwise indicated, and terminated by adding SDS sample buffer. PLK1
inhibitor BI-2536, PKD inhibitor CID755673, and pan-kinase inhibitor staurosporine
were dissolved in DMSO and added to MEE at 4ºC 15 min prior to the phosphorylation
reaction to reach a final concentration of 2 mM, 5 mM, and 5 mM, respectively.
The EIAV VLP release assay
HEK293 cells were transfected with pEV53B EIAV vector and cultured for 48 h.
Conditioned medium was collected and loaded onto a 2-ml 20% sucrose cushion in a
4-ml tube. After ultracentrifugation of the sample in an SW55-Ti rotor at 26,000 rpm for
2 h, pelleted proteins were extracted by using SDS sample buffer and immunoblotted
with anti-EIAV capsid antigen (CA) antibodies.
Immunostaining and fluorescence microscopy
Transfected HeLa cells were subcultured into chamber slides (Nunc Lab-Tek)
coated with poly-D-Lysine (Cultrex) and cultured for 48 h before being fixed with 4%
(w/v) of Paraformaldehyde at room temperature for 20 min. Fixed cells were
permeabilized with 0.2% Triton X-100 in PBS followed by blocking with 1x blocking
buffer (1% BSA, 0.25% horse serum, 0.2% Triton X-100 in PBS). Blocked cells were
first stained with primary antibodies in 0.1x blocking buffer at 4ºC overnight, and then
with Alexa Fluor 568, Alexa Fluor 488 or Alexa Fluor 647 conjugated secondary
antibodies in TBST (0.1% Triton X-100 in TBS) at room temperature for 1 h. Nuclei
were stained with DAPI (Sigma). Images were acquired using MetaMorph software
(7.7.5.0) on ZEISS Axioplan2 image system (Objective: plan-NEOFLUAR 20×/0.50 or
plan-NEOFLUAR 100×/1.30 oil).
149

Generation of rabbit polyclonal antibodies for phosphorylated ALIX at S718 and
S721
To prepare antigen, a synthetic phosphopeptide consisting of the residues 711
to 724 of ALIX and phosphorylated at both S718 and S721 (CSIAREP(pS)AP(pS)IPT)
was conjugated to keyhole limpet hemocyanin (KLH). To generate rabbit polyclonal
antibodies, rabbits were immunized with the conjugated phosphopeptide for 42 days,
and immunesera were collected. The IgG fraction of the antibodies was purified by
protein G affinity chromatography. The phosphospecificity of the purified antibodies
were evaluated with the enzyme-linked immune sorbent assay (ELISA).
Statistical analysis
Statistical analyses were performed using Student’s t-test. The p-value of ≥0.01
and <0.05 was considered significant (*). The p-value of ≥ 0.001 and <0.01 was
considered highly significant (**). The p-value of <0.001 was considered very highly
significant (***).
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